No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 2x7yB, 1.0000, 0.00, 1.000, 439, 439, P450 BM3 F87A IN COMPLEX WITH DMSO
2, 4h24C, 0.9967, 0.43, 0.970, 456, 439, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
3, 4h24A, 0.9959, 0.49, 0.970, 457, 439, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
4, 2uwhA, 0.9954, 0.51, 0.993, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
5, 1zo9A, 0.9954, 0.52, 0.995, 458, 439, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
6, 4h24B, 0.9951, 0.39, 0.973, 452, 438, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
7, 1jpzA, 0.9951, 0.54, 0.998, 456, 439, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
8, 5jq2A, 0.9950, 0.53, 0.993, 457, 439, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
9, 5jqvF, 0.9947, 0.55, 0.986, 455, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
10, 1zo9B, 0.9947, 0.55, 0.998, 458, 439, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
11, 5ucwB, 0.9946, 0.42, 0.966, 453, 438, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
12, 4zf8A, 0.9946, 0.56, 0.989, 460, 439, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND METYRAPONE
13, 1jpzB, 0.9946, 0.55, 0.998, 458, 439, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
14, 5jqvC, 0.9943, 0.57, 0.989, 452, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
15, 5e9zC, 0.9943, 0.57, 0.977, 445, 439, CYTOCHROME P450 BM3 MUTANT M11
16, 5dypC, 0.9942, 0.59, 0.993, 450, 439, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
17, 1smjA, 0.9942, 0.57, 0.995, 455, 439, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
18, 1fagA, 0.9941, 0.58, 0.998, 455, 439, STRUCTURE OF CYTOCHROME P450
19, 5jqvD, 0.9939, 0.59, 0.989, 454, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
20, 4zf6A, 0.9939, 0.60, 0.989, 460, 439, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND PEG
21, 3cbdB, 0.9939, 0.59, 0.973, 455, 439, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
22, 4zfaA, 0.9938, 0.60, 0.998, 460, 439, CYTOCHROME P450 WILD TYPE FROM BM3 WITH BOUND PEG
23, 2ij4B, 0.9938, 0.47, 0.995, 455, 438, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
24, 1fagD, 0.9938, 0.60, 0.995, 455, 439, STRUCTURE OF CYTOCHROME P450
25, 1fagC, 0.9937, 0.61, 0.995, 455, 439, STRUCTURE OF CYTOCHROME P450
26, 1fagB, 0.9937, 0.60, 0.998, 455, 439, STRUCTURE OF CYTOCHROME P450
27, 4h23B, 0.9936, 0.48, 0.968, 448, 438, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
28, 2uwhE, 0.9936, 0.61, 0.995, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
29, 4zfbA, 0.9935, 0.61, 0.989, 460, 439, CYTOCHROME P450 PENTAMUTANT FROM BM3 BOUND TO PALMITIC ACID
30, 1smjB, 0.9935, 0.61, 0.995, 455, 439, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
31, 1smiB, 0.9935, 0.49, 0.995, 455, 438, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
32, 1smjC, 0.9934, 0.61, 0.995, 455, 439, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
33, 5jquC, 0.9933, 0.62, 0.984, 453, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
34, 4kpaA, 0.9933, 0.64, 0.995, 461, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 IN COMPLEX WITH N- PALMITOYLGLYCINE (NPG)
35, 1zoaA, 0.9931, 0.52, 0.993, 457, 438, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
36, 5jqvA, 0.9930, 0.52, 0.989, 453, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
37, 5jquF, 0.9930, 0.63, 0.984, 455, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
38, 3cbdA, 0.9930, 0.64, 0.973, 455, 439, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
39, 2uwhC, 0.9929, 0.65, 0.993, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
40, 4h23A, 0.9927, 0.54, 0.968, 454, 438, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
41, 2x7yA, 0.9924, 0.41, 1.000, 437, 437, P450 BM3 F87A IN COMPLEX WITH DMSO
42, 1zoaB, 0.9921, 0.57, 0.993, 457, 438, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
43, 5jq2B, 0.9920, 0.68, 0.991, 459, 439, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
44, 2uwhB, 0.9919, 0.68, 0.993, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
45, 5jqvE, 0.9918, 0.58, 0.989, 451, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
46, 5jquE, 0.9917, 0.59, 0.984, 451, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
47, 5jquD, 0.9917, 0.70, 0.982, 454, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
48, 5xhjB, 0.9916, 0.47, 0.998, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
49, 3kx3A, 0.9914, 0.48, 0.995, 454, 437, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
50, 2ij4A, 0.9914, 0.71, 0.995, 451, 439, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
51, 5dyzA, 0.9913, 0.61, 0.993, 445, 438, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
52, 2uwhD, 0.9912, 0.72, 0.995, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
53, 5jqvB, 0.9911, 0.65, 0.982, 453, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
54, 1smjD, 0.9911, 0.62, 0.995, 454, 438, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
55, 4rsnB, 0.9910, 0.72, 0.982, 460, 439, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
56, 4rsnA, 0.9910, 0.72, 0.982, 460, 439, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
57, 2uwhF, 0.9910, 0.72, 0.993, 458, 439, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
58, 5jqvG, 0.9908, 0.65, 0.986, 451, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
59, 5ucwA, 0.9907, 0.53, 0.963, 453, 437, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
60, 4kewA, 0.9906, 0.53, 0.995, 450, 437, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
61, 3kx3B, 0.9906, 0.53, 0.993, 456, 437, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
62, 5jquA, 0.9905, 0.78, 0.982, 452, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
63, 4keyA, 0.9904, 0.54, 0.995, 450, 437, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
64, 5xhjA, 0.9903, 0.55, 0.998, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
65, 3dgiA, 0.9903, 0.63, 0.998, 449, 437, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
66, 5e9zA, 0.9899, 0.57, 0.979, 452, 437, CYTOCHROME P450 BM3 MUTANT M11
67, 5dyzC, 0.9895, 0.69, 0.991, 453, 438, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
68, 5b2wB, 0.9895, 0.46, 0.995, 452, 436, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
69, 4o4pA, 0.9895, 0.59, 0.995, 450, 437, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
70, 5jtdA, 0.9893, 0.81, 0.991, 458, 439, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
71, 5jquG, 0.9893, 0.71, 0.982, 451, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
72, 5b2wA, 0.9888, 0.50, 0.995, 452, 436, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
73, 4h24D, 0.9888, 0.51, 0.970, 455, 436, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
74, 4wg2C, 0.9887, 0.50, 0.963, 460, 436, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
75, 5jqvH, 0.9884, 0.85, 0.986, 450, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
76, 4dufC, 0.9883, 0.75, 0.986, 456, 438, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
77, 3ekfB, 0.9880, 0.41, 0.993, 452, 435, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
78, 3ekbB, 0.9880, 0.78, 0.989, 457, 438, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
79, 1bu7A, 0.9879, 0.86, 0.993, 455, 439, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
80, 4wg2B, 0.9878, 0.69, 0.963, 451, 437, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
81, 5og9B, 0.9873, 0.72, 0.986, 454, 437, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
82, 4wg2A, 0.9870, 0.61, 0.961, 461, 436, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
83, 3nplA, 0.9870, 0.47, 0.989, 456, 435, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
84, 5jquB, 0.9869, 0.72, 0.977, 453, 437, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
85, 5jquH, 0.9865, 0.92, 0.982, 450, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
86, 5dypA, 0.9865, 0.82, 0.993, 440, 438, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
87, 3nplB, 0.9861, 0.52, 0.991, 456, 435, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
88, 2j1mB, 0.9860, 0.85, 0.991, 454, 438, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
89, 4hghB, 0.9858, 0.93, 0.993, 455, 439, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
90, 4hgjA, 0.9854, 0.78, 0.993, 448, 437, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
91, 5jtdB, 0.9853, 0.95, 0.989, 458, 439, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
92, 5e9zB, 0.9852, 0.58, 0.977, 451, 435, CYTOCHROME P450 BM3 MUTANT M11
93, 4duaB, 0.9851, 0.96, 0.984, 457, 439, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
94, 2j1mA, 0.9851, 0.89, 0.991, 454, 438, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
95, 3benB, 0.9849, 0.95, 0.991, 457, 439, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
96, 5e78B, 0.9847, 0.89, 0.991, 454, 438, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
97, 4ducB, 0.9843, 0.91, 0.986, 456, 438, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
98, 5og9A, 0.9841, 0.86, 0.986, 454, 437, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
99, 4dubB, 0.9841, 0.91, 0.984, 456, 438, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
100, 3wspB, 0.9839, 0.84, 0.993, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
101, 4dueB, 0.9837, 0.93, 0.982, 450, 438, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
102, 4dueA, 0.9837, 0.93, 0.984, 453, 438, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
103, 4dudB, 0.9836, 0.93, 0.982, 456, 438, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
104, 5b2uB, 0.9835, 0.85, 0.991, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
105, 2hpdA, 0.9834, 1.01, 0.993, 457, 439, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
106, 1zo4A, 0.9833, 1.01, 0.991, 456, 439, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
107, 1fahA, 0.9832, 1.02, 0.991, 455, 439, STRUCTURE OF CYTOCHROME P450
108, 5xa3A, 0.9831, 0.87, 0.993, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
109, 5xa3D, 0.9830, 0.88, 0.991, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
110, 5b2xB, 0.9829, 0.88, 0.991, 453, 437, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
111, 5xa3C, 0.9827, 0.89, 0.993, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
112, 5xa3B, 0.9827, 0.89, 0.993, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
113, 3wspA, 0.9827, 0.89, 0.991, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
114, 3ekbA, 0.9824, 0.82, 0.993, 442, 436, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
115, 4hgjB, 0.9823, 0.72, 0.993, 451, 435, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
116, 5b2xA, 0.9821, 0.90, 0.991, 453, 437, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
117, 3qi8B, 0.9818, 0.73, 0.961, 452, 435, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
118, 4hgiB, 0.9817, 0.92, 0.991, 453, 437, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
119, 4hgiA, 0.9817, 1.06, 0.991, 455, 439, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
120, 2bmhA, 0.9816, 1.10, 0.993, 455, 439, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
121, 3kx4A, 0.9815, 0.93, 0.991, 453, 437, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
122, 5b2vB, 0.9814, 0.93, 0.993, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
123, 4hghA, 0.9813, 1.07, 0.991, 455, 439, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
124, 5b2yB, 0.9812, 0.86, 0.993, 452, 436, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
125, 5b2uA, 0.9810, 0.94, 0.989, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
126, 4o4pB, 0.9810, 0.55, 0.995, 446, 433, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
127, 5e9zD, 0.9806, 1.01, 0.977, 444, 437, CYTOCHROME P450 BM3 MUTANT M11
128, 4dtzB, 0.9806, 0.95, 0.984, 453, 437, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
129, 3benA, 0.9805, 0.88, 0.991, 454, 436, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
130, 1smiA, 0.9803, 0.70, 0.995, 439, 434, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
131, 5b2vA, 0.9801, 0.98, 0.993, 453, 437, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
132, 4dtyB, 0.9800, 0.97, 0.984, 453, 437, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
133, 5b2yA, 0.9795, 0.92, 0.993, 452, 436, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
134, 4kf2B, 0.9793, 1.12, 0.984, 448, 437, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
135, 4dtwB, 0.9793, 0.99, 0.984, 453, 437, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
136, 3ekfA, 0.9790, 0.76, 0.995, 441, 434, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
137, 1p0vA, 0.9787, 1.02, 0.989, 441, 437, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
138, 5e78A, 0.9786, 1.02, 0.991, 447, 437, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
139, 1yqoA, 0.9786, 1.02, 0.989, 441, 437, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
140, 4du2B, 0.9780, 1.04, 0.977, 444, 437, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
141, 2x80A, 0.9780, 1.17, 0.995, 455, 439, P450 BM3 F87A IN COMPLEX WITH DMSO
142, 4kf0A, 0.9779, 1.20, 0.984, 451, 437, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
143, 3ekdB, 0.9778, 1.08, 0.993, 455, 438, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
144, 2ij3A, 0.9777, 1.04, 0.991, 453, 437, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
145, 4hggB, 0.9775, 1.07, 0.995, 441, 436, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
146, 1yqpA, 0.9775, 1.05, 0.991, 441, 437, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
147, 1p0xA, 0.9773, 1.06, 0.991, 441, 437, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
148, 3kx5A, 0.9772, 0.92, 0.991, 455, 435, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
149, 2nnbA, 0.9772, 1.06, 0.989, 441, 437, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
150, 4dtzA, 0.9770, 1.07, 0.984, 453, 437, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
151, 4du2A, 0.9769, 1.07, 0.977, 443, 437, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
152, 1p0wA, 0.9768, 1.07, 0.991, 441, 437, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
153, 4kewB, 0.9767, 0.62, 0.995, 443, 431, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
154, 1jmeA, 0.9763, 1.09, 0.989, 441, 437, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
155, 4hgfB, 0.9760, 1.03, 0.991, 441, 435, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
156, 4dufD, 0.9760, 1.17, 0.986, 456, 438, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
157, 4dtwA, 0.9759, 1.10, 0.982, 453, 437, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
158, 3ekdA, 0.9758, 1.20, 0.995, 454, 439, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
159, 4hgfA, 0.9749, 1.16, 0.993, 442, 436, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
160, 3m4vA, 0.9749, 0.99, 0.991, 451, 435, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
161, 4keyB, 0.9747, 0.61, 0.995, 442, 430, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
162, 2ij2B, 0.9739, 0.88, 0.993, 448, 433, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
163, 5e7yA, 0.9737, 1.03, 0.991, 451, 435, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
164, 4dtyA, 0.9733, 1.17, 0.984, 453, 437, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
165, 1bu7B, 0.9728, 1.31, 0.993, 455, 439, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
166, 2ij3B, 0.9725, 1.26, 0.991, 454, 438, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
167, 4kf2A, 0.9723, 1.34, 0.984, 451, 437, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
168, 4duaA, 0.9722, 1.33, 0.982, 457, 439, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
169, 4kpbA, 0.9717, 1.13, 0.995, 440, 435, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
170, 2j4sA, 0.9717, 1.15, 0.991, 452, 436, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
171, 4kf0B, 0.9712, 1.24, 0.995, 441, 435, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
172, 1fahB, 0.9712, 1.36, 0.991, 455, 439, STRUCTURE OF CYTOCHROME P450
173, 3m4vB, 0.9710, 1.04, 0.991, 438, 434, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
174, 1zo4B, 0.9707, 1.37, 0.991, 457, 439, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
175, 4dufA, 0.9703, 1.32, 0.986, 456, 438, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
176, 2bmhB, 0.9703, 1.38, 0.993, 455, 439, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
177, 2hpdB, 0.9702, 1.39, 0.993, 457, 439, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
178, 2x80B, 0.9692, 1.41, 0.993, 455, 439, P450 BM3 F87A IN COMPLEX WITH DMSO
179, 4dubA, 0.9688, 1.36, 0.984, 456, 438, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
180, 1yqoB, 0.9687, 1.31, 0.991, 441, 437, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
181, 4ducA, 0.9683, 1.38, 0.986, 456, 438, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
182, 4hggA, 0.9678, 0.99, 0.988, 435, 431, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
183, 4dudA, 0.9678, 1.39, 0.984, 456, 438, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
184, 2nnbB, 0.9656, 1.38, 0.991, 441, 437, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
185, 1yqpB, 0.9654, 1.39, 0.991, 441, 437, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
186, 1p0wB, 0.9651, 1.40, 0.991, 448, 437, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
187, 2j4sB, 0.9649, 1.23, 0.991, 450, 434, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
188, 5e7yB, 0.9646, 1.35, 0.991, 452, 436, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
189, 4kpbB, 0.9645, 1.36, 0.995, 444, 436, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
190, 3kx5B, 0.9642, 1.42, 0.995, 455, 437, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
191, 3dgiB, 0.9642, 0.56, 0.998, 425, 425, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
192, 1jmeB, 0.9641, 1.43, 0.989, 441, 437, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
193, 3kx4B, 0.9640, 1.49, 0.963, 454, 438, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
194, 1p0vB, 0.9640, 1.43, 0.991, 444, 437, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
195, 4dufB, 0.9639, 1.49, 0.957, 456, 438, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
196, 1p0xB, 0.9635, 1.44, 0.991, 448, 437, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
197, 2ij2A, 0.9621, 1.47, 0.991, 450, 437, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
198, 3hf2A, 0.9613, 0.94, 0.993, 428, 427, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
199, 3hf2B, 0.9466, 1.17, 0.988, 423, 423, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
200, 3qi8A, 0.9359, 0.77, 0.959, 424, 415, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
201, 3psxB, 0.9313, 0.55, 0.988, 414, 411, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
202, 3psxA, 0.9298, 0.51, 0.988, 412, 410, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
203, 1bvyA, 0.9298, 1.33, 0.990, 439, 420, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
204, 1bvyB, 0.9291, 1.29, 0.988, 438, 419, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
205, 6c93A, 0.8959, 2.54, 0.234, 478, 427, EFFECTS OF THE E310A MUTATION OF CYTOCHROME P450 4B1 (CYP4B1) ON N- OCTANE BINDING AND HEME RUFFLING 
206, 6c94A, 0.8953, 2.55, 0.230, 482, 427, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH THE INHIBITOR HET0016 
207, 5t6qA, 0.8933, 2.36, 0.232, 472, 423, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH OCTANE: AN N- ALKANE AND FATTY ACID OMEGA-HYDROXYLASE WITH A COVALENTLY BOUND HEME
208, 5veuC, 0.8844, 2.64, 0.265, 469, 426, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
209, 2v0mC, 0.8784, 2.72, 0.270, 465, 426, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
210, 5veuI, 0.8775, 2.61, 0.270, 464, 422, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
211, 3na1A, 0.8764, 2.77, 0.195, 472, 426, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
212, 2ve3A, 0.8761, 2.47, 0.212, 435, 419, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
213, 3na0A, 0.8749, 2.76, 0.195, 470, 425, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
214, 3na1B, 0.8746, 2.79, 0.195, 471, 426, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
215, 3n9yA, 0.8737, 2.78, 0.193, 471, 425, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
216, 3na0B, 0.8736, 2.78, 0.195, 470, 425, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
217, 3n9zA, 0.8736, 2.78, 0.193, 470, 425, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
218, 1tqnA, 0.8735, 2.93, 0.257, 468, 428, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 3A4
219, 5eshA, 0.8727, 3.06, 0.137, 528, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT IN COMPLEX WITH ITRACONAZOLE
220, 3n9zB, 0.8727, 2.81, 0.195, 470, 425, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
221, 5eafA, 0.8725, 3.06, 0.137, 528, 432, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
222, 3n9yB, 0.8725, 2.80, 0.195, 470, 425, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
223, 5a1pA, 0.8724, 2.91, 0.260, 465, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE AND CITRATE
224, 5esjA, 0.8723, 3.01, 0.132, 528, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH FLUCONAZOLE
225, 5eagA, 0.8723, 3.00, 0.135, 528, 431, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR PROCHLORAZ
226, 5eacA, 0.8722, 3.05, 0.137, 530, 432, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-TEBUCONAZOLE
227, 4lxjA, 0.8722, 3.05, 0.137, 530, 432, SACCHAROMYCES CEREVISIAE LANOSTEROL 14-ALPHA DEMETHYLASE WITH LANOSTEROL BOUND
228, 5veuK, 0.8721, 2.55, 0.267, 458, 419, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
229, 5esmA, 0.8721, 3.06, 0.137, 528, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH FLUCONAZOLE
230, 3k9yA, 0.8721, 2.74, 0.198, 461, 425, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
231, 5eseA, 0.8720, 3.06, 0.137, 528, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73R MUTANT COMPLEXED WITH FLUCONAZOLE
232, 5eadA, 0.8720, 3.01, 0.135, 529, 431, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-DESTHIO-PROTHIOCONAZOLE
233, 4ze3A, 0.8720, 3.02, 0.135, 526, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH FLUCONAZOLE
234, 4ze0A, 0.8720, 3.01, 0.135, 530, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH VORICONAZOLE
235, 5esnA, 0.8719, 3.01, 0.135, 528, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT STRUCTURE
236, 5esfA, 0.8719, 3.10, 0.141, 524, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH FLUCONAZOLE
237, 5eafB, 0.8719, 3.01, 0.135, 528, 431, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
238, 4wmzA, 0.8719, 3.02, 0.135, 527, 431, S. CEREVISIAE CYP51 COMPLEXED WITH FLUCONAZOLE IN THE ACTIVE SITE
239, 2v0mA, 0.8719, 2.72, 0.270, 455, 423, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
240, 5ul0A, 0.8718, 3.02, 0.135, 528, 431, S. CEREVISIAE CYP51 COMPLEXED WITH VT-1161
241, 3k9vB, 0.8718, 2.69, 0.203, 464, 424, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
242, 5veuJ, 0.8717, 2.65, 0.267, 458, 420, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
243, 4zdzA, 0.8717, 3.02, 0.135, 529, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH FLUCONAZOLE
244, 5hs1A, 0.8716, 3.06, 0.137, 528, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) COMPLEXED WITH VORICONAZOLE
245, 5veuB, 0.8714, 2.66, 0.262, 458, 420, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
246, 5eaeA, 0.8714, 3.07, 0.137, 529, 432, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-DESTHIO-PROTHIOCONAZOLE
247, 4ze2A, 0.8714, 3.03, 0.135, 529, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH ITRACONAZOLE
248, 5esgA, 0.8713, 3.08, 0.137, 526, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH ITRACONAZOLE
249, 5eslA, 0.8711, 3.04, 0.135, 527, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH ITRACONAZOLE
250, 5esiA, 0.8710, 3.02, 0.135, 530, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT
251, 4ze1A, 0.8710, 3.03, 0.135, 528, 431, SACCHAROMYCES CEREVISIAE CYP51 Y140F MUTANT COMPLEXED WITH POSACONAZOLE IN THE ACTIVE SITE
252, 3k9yB, 0.8710, 2.71, 0.203, 462, 424, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
253, 6bdiA, 0.8709, 2.89, 0.261, 462, 426, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
254, 5eqbA, 0.8709, 3.07, 0.137, 531, 432, CRYSTAL STRUCTURE OF LANOSTEROL 14-ALPHA DEMETHYLASE WITH INTACT TRANSMEMBRANE DOMAIN BOUND TO ITRACONAZOLE
255, 5eskA, 0.8708, 3.04, 0.132, 527, 431, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH ITRACONAZOLE
256, 5veuD, 0.8707, 2.63, 0.264, 459, 420, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
257, 5eahA, 0.8707, 3.07, 0.137, 529, 432, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR DIFENOCONAZOLE
258, 5eabA, 0.8707, 3.07, 0.137, 525, 432, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-TEBUCONAZOLE
259, 4zdyA, 0.8707, 3.09, 0.137, 527, 432, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH ITRACONAZOLE
260, 4fdhE, 0.8706, 2.64, 0.190, 470, 422, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
261, 2v0mD, 0.8706, 2.69, 0.271, 453, 421, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
262, 4i4hA, 0.8702, 2.72, 0.265, 457, 422, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO PYRIDINE-SUBSTITUTED DESOXYRITONAVIR
263, 4fdhF, 0.8702, 2.62, 0.190, 469, 421, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
264, 5veuF, 0.8701, 2.67, 0.264, 456, 420, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
265, 6bdkA, 0.8700, 2.90, 0.261, 461, 426, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
266, 5veuG, 0.8698, 2.69, 0.267, 455, 420, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
267, 4dvqF, 0.8698, 2.63, 0.192, 469, 421, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
268, 6bd7A, 0.8697, 2.94, 0.260, 462, 427, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
269, 5veuH, 0.8696, 2.66, 0.264, 459, 420, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
270, 6bczA, 0.8695, 2.91, 0.261, 461, 426, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
271, 3mzsD, 0.8695, 2.85, 0.181, 470, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
272, 5veuA, 0.8694, 2.78, 0.262, 462, 423, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
273, 4dvqE, 0.8694, 2.66, 0.190, 470, 422, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
274, 3mzsC, 0.8694, 2.85, 0.184, 470, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
275, 3mzsB, 0.8693, 2.85, 0.181, 470, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
276, 5tz1A, 0.8692, 2.98, 0.147, 484, 430, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
277, 5vcgA, 0.8691, 2.87, 0.264, 461, 424, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO BROMOERGOCRYPTINE
278, 5tz1B, 0.8691, 2.97, 0.144, 484, 430, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
279, 5a1rA, 0.8691, 2.93, 0.261, 462, 426, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE
280, 4i3qA, 0.8689, 2.95, 0.258, 465, 426, CRYSTAL STRUCTURE OF HUMAN CYP3A4 COORDINATED TO A WATER MOLECULE
281, 3mzsA, 0.8687, 2.88, 0.181, 470, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
282, 3nxuA, 0.8684, 2.74, 0.265, 457, 422, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
283, 4k9wC, 0.8683, 2.76, 0.270, 458, 422, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
284, 3ua1A, 0.8680, 2.83, 0.262, 456, 423, CRYSTAL STRUCTURE OF THE CYTOCHROME P4503A4-BROMOERGOCRYPTINE COMPLEX
285, 5vcdA, 0.8678, 2.87, 0.267, 460, 423, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO GLYCEROL
286, 3nxuB, 0.8677, 2.75, 0.268, 457, 422, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
287, 3k9vA, 0.8677, 2.77, 0.203, 464, 424, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
288, 4d75A, 0.8673, 2.92, 0.261, 460, 425, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
289, 5vccA, 0.8672, 2.87, 0.265, 457, 423, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO GLYCEROL
290, 4k9wD, 0.8669, 2.77, 0.268, 458, 422, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
291, 5te8B, 0.8663, 2.87, 0.262, 471, 423, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
292, 4fdhK, 0.8661, 2.79, 0.186, 469, 424, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
293, 4k9wB, 0.8660, 2.80, 0.265, 457, 422, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
294, 5vceA, 0.8657, 2.89, 0.267, 457, 423, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO RITONAVIR
295, 6bd5A, 0.8655, 2.92, 0.259, 457, 424, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
296, 5te8A, 0.8655, 2.96, 0.262, 470, 424, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
297, 4zgxD, 0.8654, 2.74, 0.195, 465, 421, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
298, 2ve3B, 0.8653, 2.39, 0.214, 427, 412, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
299, 2v0mB, 0.8653, 2.75, 0.268, 451, 421, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
300, 4d7dA, 0.8652, 2.80, 0.268, 458, 422, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
301, 4d78A, 0.8652, 2.76, 0.268, 459, 421, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
302, 4fdhD, 0.8651, 2.68, 0.195, 465, 420, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
303, 4k9wA, 0.8650, 2.85, 0.265, 458, 423, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
304, 4ny4A, 0.8648, 2.91, 0.259, 460, 424, CRYSTAL STRUCTURE OF CYP3A4 IN COMPLEX WITH AN INHIBITOR
305, 6bdmA, 0.8646, 2.95, 0.264, 456, 424, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
306, 6bd8A, 0.8646, 2.92, 0.259, 457, 424, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
307, 4i4gA, 0.8646, 2.75, 0.264, 459, 421, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO OXAZOLE-SUBSTITUTED DESOXYRITONAVIR
308, 4zgxA, 0.8642, 2.75, 0.190, 465, 421, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
309, 1w0fA, 0.8642, 2.92, 0.264, 459, 424, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
310, 4zgxJ, 0.8637, 2.61, 0.196, 463, 418, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
311, 4zgxG, 0.8637, 2.69, 0.190, 465, 420, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
312, 4d6zA, 0.8637, 2.81, 0.264, 460, 421, CYTOCHROME P450 3A4 BOUND TO IMIDAZOLE AND AN INHIBITOR
313, 5fsaA, 0.8635, 3.11, 0.139, 484, 431, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
314, 4fdhB, 0.8635, 2.75, 0.190, 465, 421, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
315, 4k9tA, 0.8634, 2.87, 0.258, 455, 422, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
316, 4uymA, 0.8627, 3.04, 0.164, 470, 427, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
317, 4uhlF, 0.8626, 2.83, 0.194, 445, 422, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
318, 6bd6A, 0.8624, 2.93, 0.262, 457, 423, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
319, 5vc0A, 0.8623, 2.93, 0.264, 463, 424, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO RITONAVIR
320, 4fdhG, 0.8623, 2.67, 0.193, 463, 419, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
321, 4zgxC, 0.8620, 2.72, 0.188, 465, 420, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
322, 4zgxB, 0.8619, 2.72, 0.188, 465, 420, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
323, 5jlcA, 0.8617, 3.10, 0.124, 506, 428, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA GLABRATA
324, 4zgxK, 0.8617, 2.84, 0.193, 461, 420, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
325, 4zgxH, 0.8617, 2.72, 0.193, 465, 420, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
326, 4uhlE, 0.8617, 2.86, 0.192, 445, 422, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
327, 4dvqG, 0.8616, 2.62, 0.192, 462, 417, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
328, 4uhlG, 0.8615, 2.86, 0.194, 445, 422, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
329, 4k9vA, 0.8615, 2.85, 0.264, 456, 421, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
330, 3ld6A, 0.8615, 2.96, 0.198, 445, 425, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
331, 6aycA, 0.8614, 3.01, 0.190, 449, 426, NAEGLERIA FOWLERI CYP51-ITRACONAZOLE COMPLEX
332, 4uhlH, 0.8613, 2.87, 0.192, 445, 422, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
333, 2ve4B, 0.8610, 2.64, 0.212, 432, 416, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
334, 5te8C, 0.8608, 2.94, 0.263, 469, 422, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
335, 5frbA, 0.8608, 3.09, 0.164, 470, 427, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH A TETRAZOLE-BASED INHIBITOR VT-1598
336, 4uhlD, 0.8608, 2.87, 0.194, 445, 422, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
337, 4fdhA, 0.8604, 2.68, 0.189, 463, 418, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
338, 3ld6B, 0.8604, 2.93, 0.203, 444, 424, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
339, 2j0dA, 0.8604, 2.92, 0.262, 446, 420, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
340, 4zgxF, 0.8603, 2.70, 0.189, 464, 419, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
341, 4dvqB, 0.8603, 2.68, 0.189, 463, 418, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
342, 3jusB, 0.8603, 2.96, 0.200, 445, 425, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
343, 5fsaB, 0.8602, 3.13, 0.142, 483, 430, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
344, 4dvqA, 0.8602, 2.68, 0.194, 463, 418, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
345, 4uymB, 0.8601, 3.12, 0.166, 470, 427, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
346, 3jusA, 0.8600, 3.00, 0.197, 445, 426, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
347, 4uhlC, 0.8599, 2.89, 0.194, 445, 422, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
348, 4uhlA, 0.8599, 2.89, 0.192, 445, 422, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
349, 6ay4A, 0.8597, 3.08, 0.190, 450, 427, NAEGLERIA FOWLERI CYP51-FLUCONAZOLE COMPLEX
350, 4fdhC, 0.8597, 2.66, 0.197, 462, 417, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
351, 4dvqC, 0.8597, 2.66, 0.192, 462, 417, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
352, 3tjsA, 0.8596, 2.87, 0.271, 449, 421, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN CYTOCHROME P450 3A4 AND DESTHIAZOLYLMETHYLOXYCARBONYL RITONAVIR
353, 4dvqD, 0.8593, 2.68, 0.187, 462, 417, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
354, 4zgxL, 0.8592, 2.70, 0.191, 462, 418, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
355, 4uhlB, 0.8590, 2.91, 0.190, 445, 422, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
356, 3tbgA, 0.8590, 3.13, 0.171, 467, 426, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
357, 3tbgC, 0.8589, 3.20, 0.173, 467, 427, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
358, 2ve4A, 0.8588, 2.70, 0.204, 431, 417, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
359, 4uylB, 0.8586, 3.08, 0.166, 470, 427, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
360, 6cr2B, 0.8585, 3.08, 0.167, 469, 426, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
361, 5v5zA, 0.8585, 3.07, 0.141, 488, 426, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA ALBICANS
362, 4uylA, 0.8585, 3.19, 0.165, 470, 430, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
363, 2q9fA, 0.8583, 2.40, 0.222, 433, 405, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1 IN COMPLEX WITH CHOLESTEROL-3-SULPHATE
364, 4dvqH, 0.8581, 2.70, 0.189, 462, 417, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
365, 4j14A, 0.8580, 2.50, 0.221, 436, 407, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH POSACONAZOLE BOUND
366, 5g5jA, 0.8579, 2.92, 0.266, 452, 421, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO METFORMIN
367, 4k9uA, 0.8579, 2.91, 0.269, 450, 420, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
368, 6cr2A, 0.8578, 3.11, 0.164, 469, 426, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
369, 5veuL, 0.8578, 2.62, 0.268, 448, 414, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
370, 4zgxE, 0.8577, 2.58, 0.193, 459, 414, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
371, 5tl8A, 0.8576, 3.05, 0.191, 448, 425, NAEGLERIA FOWLERI CYP51-POSACONAZOLE COMPLEX
372, 4fdhH, 0.8576, 2.69, 0.189, 462, 417, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
373, 4fdhI, 0.8574, 2.69, 0.189, 462, 417, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
374, 3mdmA, 0.8572, 2.49, 0.221, 435, 407, THIOPERAMIDE COMPLEX OF CYTOCHROME P450 46A1
375, 4uhiD, 0.8571, 2.82, 0.196, 442, 419, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
376, 4dvqJ, 0.8571, 2.73, 0.191, 462, 418, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
377, 4kq8A, 0.8570, 2.92, 0.197, 452, 422, STRUCTURE OF RECOMBINANT HUMAN CYTOCHROME P450 AROMATASE
378, 6ay6A, 0.8566, 3.06, 0.191, 448, 425, NAEGLERIA FOWLERI CYP51-VORICONAZOLE COMPLEX
379, 4uhiA, 0.8566, 2.83, 0.193, 442, 419, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
380, 3s79A, 0.8566, 2.92, 0.197, 452, 422, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) REFINED AT 2.75 ANGSTROM
381, 6aybA, 0.8565, 3.03, 0.191, 447, 424, NAEGLERIA FOWLERI CYP51-KETOCONAZOLE COMPLEX
382, 5jl9A, 0.8565, 2.92, 0.197, 452, 422, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #4
383, 3eqmA, 0.8565, 2.92, 0.197, 452, 422, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE CYTOCHROME P450 IN COMPLEX WITH ANDROSTENEDIONE
384, 5jkwA, 0.8564, 2.93, 0.197, 452, 422, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) COMPLEXED WITH TESTOSTERONE
385, 5jl7A, 0.8563, 2.93, 0.197, 452, 422, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #3
386, 5jkvA, 0.8563, 2.93, 0.197, 452, 422, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) AT 2.75 ANGSTROM WITH BOUND POLYETHYLENE GLYCOL
387, 4zgxI, 0.8562, 2.56, 0.194, 458, 413, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
388, 4dvqI, 0.8562, 2.74, 0.196, 462, 418, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
389, 3s7sA, 0.8562, 2.93, 0.197, 452, 422, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH BREAST CANCER DRUG EXEMESTANE
390, 5jl6A, 0.8561, 2.94, 0.197, 452, 422, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #2
391, 4k9xA, 0.8561, 2.82, 0.264, 449, 417, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
392, 3mdrA, 0.8559, 2.51, 0.222, 427, 406, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
393, 5tftA, 0.8558, 3.18, 0.171, 467, 426, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
394, 6b82B, 0.8556, 3.22, 0.194, 470, 428, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
395, 4fdhL, 0.8556, 2.57, 0.194, 456, 413, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
396, 3l4dB, 0.8556, 2.90, 0.188, 449, 421, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
397, 4uhiB, 0.8555, 2.84, 0.196, 442, 419, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
398, 3l4dC, 0.8555, 2.84, 0.186, 447, 420, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
399, 4uhiC, 0.8554, 2.86, 0.193, 442, 419, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
400, 3l4dD, 0.8552, 2.91, 0.188, 445, 421, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
401, 3l4dA, 0.8552, 2.85, 0.186, 448, 420, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
402, 4fdhJ, 0.8550, 2.77, 0.187, 462, 418, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
403, 4gl5A, 0.8549, 2.95, 0.197, 452, 422, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG029 (COMPOUND 4)
404, 4fiaA, 0.8549, 2.46, 0.222, 426, 405, CRYSTAL STRUCTURE OF HUMAN CYP46A1 P450 WITH BICALUTAMIDE BOUND
405, 3qm4A, 0.8549, 3.11, 0.177, 465, 424, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
406, 4wnvA, 0.8543, 3.10, 0.173, 464, 423, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
407, 4ck8B, 0.8542, 2.88, 0.186, 450, 420, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
408, 3mdrB, 0.8542, 2.43, 0.223, 425, 404, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
409, 4gl7A, 0.8540, 2.97, 0.197, 452, 422, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG046 (COMPOUND 5)
410, 3k1oA, 0.8539, 2.81, 0.187, 442, 418, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH A POTENTIAL ANTICHAGASIC DRUG POSACONAZOLE
411, 1w0gA, 0.8536, 2.99, 0.267, 455, 420, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
412, 2wuzB, 0.8535, 2.94, 0.183, 444, 421, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
413, 2j0dB, 0.8535, 2.86, 0.262, 445, 416, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
414, 4ck8A, 0.8533, 2.92, 0.186, 449, 420, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
415, 3mdtB, 0.8532, 2.37, 0.221, 424, 403, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
416, 3tdaC, 0.8528, 3.24, 0.171, 467, 426, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
417, 3qm4B, 0.8527, 3.31, 0.172, 457, 425, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
418, 4enhA, 0.8525, 2.46, 0.223, 426, 404, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH FLUVOXAMINE BOUND
419, 3mdvB, 0.8525, 2.39, 0.221, 424, 403, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
420, 3mdvA, 0.8525, 2.39, 0.221, 424, 403, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
421, 4g7gC, 0.8523, 2.74, 0.184, 448, 414, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
422, 3zg2A, 0.8523, 2.93, 0.186, 449, 420, STEROL 14 ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR (S)-2-(4-CHLOROPHENYL)-2- (PYRIDIN-3-YL)-1-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL) ETHANONE (EPL-BS1246UDO)
423, 4dvqK, 0.8522, 2.74, 0.190, 460, 416, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
424, 2q9gA, 0.8520, 2.50, 0.220, 422, 404, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1
425, 3tdaA, 0.8519, 3.25, 0.171, 467, 426, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
426, 4dvqL, 0.8518, 2.57, 0.192, 454, 411, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
427, 4bjkD, 0.8516, 2.81, 0.187, 444, 416, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
428, 5ajrA, 0.8515, 2.96, 0.188, 449, 420, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE 1-TETRAZOLE DERIVATIVE VT-1161 ((R)-2-( 24-DIFLUOROPHENYL)-11-DIFLUORO-3-(1H-TETRAZOL-1-YL)-1-(5- (4-(222-TRIFLUOROETHOXY)PHENYL)PYRIDIN-2-YL)PROPAN-2-OL)
429, 3tikC, 0.8514, 2.80, 0.183, 450, 415, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
430, 6b82A, 0.8513, 3.05, 0.199, 465, 422, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
431, 4cohB, 0.8512, 3.00, 0.185, 445, 421, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
432, 4ckaA, 0.8511, 2.84, 0.187, 434, 418, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-FLUOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFS)
433, 4bmmB, 0.8511, 2.86, 0.189, 442, 418, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
434, 3mdtA, 0.8511, 2.41, 0.223, 424, 403, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
435, 4ck9A, 0.8510, 2.84, 0.187, 434, 418, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-CHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFT)
436, 3dl9B, 0.8505, 3.23, 0.211, 467, 427, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
437, 3zg3A, 0.8504, 2.86, 0.187, 445, 418, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR N-(1-(5-( TRIFLUOROMETHYL)(PYRIDIN-2-YL))PIPERIDIN-4YL)-N-(4-( TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-AMINE (EPL-BS967 UDD)
438, 4bjkC, 0.8503, 2.83, 0.185, 450, 416, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
439, 3c6gB, 0.8503, 3.23, 0.215, 467, 427, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
440, 4g7gB, 0.8502, 2.75, 0.184, 448, 414, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
441, 3juvA, 0.8502, 3.14, 0.190, 448, 422, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51)
442, 3czhB, 0.8501, 3.25, 0.213, 467, 427, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
443, 4xryA, 0.8499, 3.19, 0.173, 464, 423, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
444, 4bjkA, 0.8499, 2.83, 0.185, 450, 416, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
445, 4cohA, 0.8498, 2.89, 0.182, 442, 418, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
446, 3tikB, 0.8498, 2.93, 0.186, 450, 419, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
447, 3gw9A, 0.8498, 2.85, 0.185, 450, 416, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
448, 3gw9D, 0.8497, 2.83, 0.186, 449, 415, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
449, 3g1qB, 0.8497, 2.90, 0.184, 444, 418, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
450, 4bjkB, 0.8496, 2.85, 0.185, 450, 416, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
451, 4wnwA, 0.8495, 3.14, 0.175, 461, 422, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
452, 4h6oA, 0.8495, 2.87, 0.187, 435, 418, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE INHIBITOR NEU321 (1-(3-(4-CHLORO-35-DIMETHYLPHENOXY) BENZYL)-1H-IMIDAZOLE
453, 4g3jC, 0.8495, 2.80, 0.184, 448, 414, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
454, 3p99D, 0.8495, 2.92, 0.184, 448, 418, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
455, 2x2nA, 0.8494, 2.81, 0.186, 448, 415, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
456, 2x2nC, 0.8492, 2.77, 0.188, 441, 414, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
457, 2wuzA, 0.8492, 2.91, 0.182, 444, 418, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
458, 1nr6A, 0.8491, 3.30, 0.183, 462, 427, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH DICLOFENAC
459, 3p99A, 0.8490, 2.92, 0.187, 448, 418, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
460, 4g7gD, 0.8487, 2.79, 0.184, 448, 414, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
461, 5veuE, 0.8486, 2.58, 0.274, 441, 409, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
462, 3g1qD, 0.8486, 2.90, 0.185, 448, 417, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
463, 3g1qC, 0.8486, 2.79, 0.188, 447, 414, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
464, 3tikA, 0.8485, 2.82, 0.186, 450, 415, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
465, 2x2nD, 0.8485, 2.78, 0.188, 447, 414, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
466, 3tikD, 0.8484, 2.86, 0.180, 450, 416, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
467, 3p99C, 0.8484, 2.94, 0.184, 444, 418, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
468, 3gw9C, 0.8484, 2.91, 0.187, 449, 418, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
469, 4g3jA, 0.8483, 2.92, 0.184, 448, 418, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
470, 3khmA, 0.8481, 3.00, 0.189, 441, 419, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH INHIBITOR FLUCONAZOLE
471, 4g3jD, 0.8479, 2.82, 0.178, 448, 415, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
472, 1w0eA, 0.8479, 2.91, 0.264, 450, 416, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
473, 2x2nB, 0.8477, 2.79, 0.186, 444, 414, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
474, 5tftB, 0.8476, 3.15, 0.169, 460, 421, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
475, 4bmmA, 0.8476, 2.92, 0.189, 441, 418, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
476, 3g1qA, 0.8471, 2.95, 0.179, 448, 418, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
477, 2wv2A, 0.8468, 2.81, 0.188, 443, 414, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA BRUCEI IN COMPLEX WITH FLUCONAZOLE
478, 6bdhA, 0.8467, 2.82, 0.266, 439, 413, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
479, 4c27B, 0.8467, 2.98, 0.189, 443, 419, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
480, 4c27A, 0.8463, 3.02, 0.188, 444, 420, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
481, 3p99B, 0.8463, 2.91, 0.187, 448, 417, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
482, 4g7gA, 0.8462, 2.87, 0.178, 448, 415, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
483, 4c0cA, 0.8458, 2.97, 0.182, 446, 417, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(24-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
484, 3dl9A, 0.8456, 3.33, 0.209, 465, 426, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
485, 3czhA, 0.8456, 3.34, 0.211, 465, 427, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
486, 3gw9B, 0.8454, 3.01, 0.181, 449, 419, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
487, 4g3jB, 0.8453, 2.90, 0.178, 448, 415, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
488, 4c28B, 0.8453, 2.97, 0.189, 441, 418, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
489, 4bmmD, 0.8452, 2.98, 0.187, 442, 418, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
490, 1n6bA, 0.8450, 3.23, 0.178, 462, 422, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH A DIMETHYL DERIVATIVE OF SULFAPHENAZOLE
491, 3c6gA, 0.8449, 3.26, 0.210, 464, 424, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
492, 4xrzB, 0.8447, 3.15, 0.170, 458, 418, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
493, 4c28A, 0.8446, 3.01, 0.189, 443, 419, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
494, 4wnwB, 0.8440, 3.23, 0.173, 452, 421, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
495, 2vn0A, 0.8437, 3.32, 0.181, 464, 426, CYP2C8DH COMPLEXED WITH TROGLITAZONE
496, 4uvrA, 0.8435, 2.88, 0.181, 439, 414, BINDING MODE SELECTIVITY AND POTENCY OF N-INDOLYL- OXOPYRIDINYL-4-AMINO-PROPANYL-BASED INHIBITORS TARGETING TRYPANOSOMA CRUZI CYP51
497, 4by0A, 0.8433, 2.94, 0.186, 441, 414, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
498, 4uqhA, 0.8431, 2.98, 0.183, 443, 416, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(34-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
499, 4bmmC, 0.8430, 2.95, 0.187, 440, 416, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
500, 3ua5A, 0.8428, 3.37, 0.178, 465, 427, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
501, 4gqsA, 0.8427, 3.32, 0.190, 464, 426, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
502, 4i8vB, 0.8426, 3.30, 0.185, 472, 428, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
503, 4by0B, 0.8420, 2.99, 0.192, 442, 417, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
504, 4xrzA, 0.8415, 3.10, 0.168, 457, 416, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
505, 2nnhA, 0.8411, 3.29, 0.184, 463, 424, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
506, 2nnjA, 0.8409, 3.31, 0.186, 463, 424, CYP2C8DH COMPLEXED WITH FELODIPINE
507, 3ua5B, 0.8403, 3.33, 0.176, 462, 425, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
508, 1pq2B, 0.8403, 3.34, 0.184, 463, 425, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
509, 2nniA, 0.8401, 3.31, 0.186, 463, 424, CYP2C8DH COMPLEXED WITH MONTELUKAST
510, 2wx2A, 0.8397, 2.96, 0.181, 441, 415, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
511, 2nnhB, 0.8391, 3.36, 0.181, 463, 425, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
512, 4wntA, 0.8388, 3.15, 0.168, 457, 416, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
513, 4i8vD, 0.8387, 3.28, 0.190, 467, 426, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
514, 4ejhG, 0.8387, 3.38, 0.198, 463, 425, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
515, 1pq2A, 0.8385, 3.30, 0.185, 463, 422, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
516, 2hi4A, 0.8382, 3.43, 0.195, 480, 430, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 1A2 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
517, 4xryB, 0.8380, 3.16, 0.173, 455, 416, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
518, 1dt6A, 0.8380, 3.26, 0.176, 449, 420, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2C5
519, 4i8vC, 0.8375, 3.34, 0.185, 468, 427, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
520, 5e0eA, 0.8372, 3.31, 0.185, 463, 421, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B37 FROM DESERT WOODRAT IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
521, 4ejhH, 0.8372, 3.30, 0.197, 459, 422, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
522, 4i8vA, 0.8371, 3.49, 0.186, 477, 430, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
523, 4wnvC, 0.8368, 3.13, 0.171, 454, 414, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
524, 4gqsB, 0.8366, 3.33, 0.186, 456, 424, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
525, 6chiA, 0.8360, 3.36, 0.220, 466, 422, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
526, 5uysA, 0.8360, 3.35, 0.218, 471, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
527, 5uysB, 0.8358, 3.34, 0.218, 470, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
528, 6chiB, 0.8357, 3.30, 0.219, 468, 421, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
529, 6cizA, 0.8354, 3.30, 0.219, 468, 421, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
530, 4ejgG, 0.8353, 3.38, 0.196, 463, 424, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
531, 2fdwB, 0.8352, 3.50, 0.192, 465, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
532, 6cizB, 0.8351, 3.31, 0.219, 469, 421, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
533, 4y8wA, 0.8350, 3.04, 0.201, 440, 412, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
534, 4nkvA, 0.8350, 3.36, 0.218, 466, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
535, 5vbuA, 0.8348, 3.16, 0.203, 442, 414, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
536, 3ebsB, 0.8347, 3.58, 0.194, 466, 428, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
537, 4nz2A, 0.8345, 3.40, 0.194, 464, 423, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
538, 3ibdA, 0.8345, 3.51, 0.173, 465, 428, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2B6 GENETIC VARIANT IN COMPLEX WITH THE INHIBITOR 4-(4-CHLOROPHENYL)IMIDAZOLE
539, 2wx2B, 0.8345, 3.10, 0.182, 444, 417, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
540, 5irqB, 0.8344, 3.32, 0.219, 467, 421, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
541, 5irvB, 0.8343, 3.32, 0.219, 471, 421, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
542, 2pg7B, 0.8342, 3.51, 0.192, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
543, 4nz2B, 0.8341, 3.40, 0.187, 464, 423, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
544, 4nkwA, 0.8341, 3.39, 0.218, 464, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
545, 5vbuC, 0.8339, 3.16, 0.203, 442, 414, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
546, 4nkvB, 0.8338, 3.33, 0.219, 467, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
547, 5irqA, 0.8337, 3.33, 0.219, 466, 421, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
548, 2p85B, 0.8337, 3.49, 0.195, 464, 426, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
549, 1suoA, 0.8337, 3.45, 0.172, 465, 425, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4 WITH BOUND 4-(4- CHLOROPHENYL)IMIDAZOLE
550, 4nkwB, 0.8336, 3.39, 0.220, 464, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
551, 1z11B, 0.8334, 3.51, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
552, 3el3B, 0.8333, 2.75, 0.204, 417, 406, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
553, 5irvA, 0.8331, 3.33, 0.219, 471, 421, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
554, 4nkxB, 0.8331, 3.39, 0.220, 468, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
555, 4ejgH, 0.8331, 3.26, 0.193, 458, 420, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
556, 3swzA, 0.8331, 3.39, 0.218, 471, 422, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
557, 1z10B, 0.8331, 3.55, 0.194, 465, 427, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
558, 6cirA, 0.8330, 3.41, 0.218, 466, 422, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
559, 4y8wC, 0.8330, 3.18, 0.203, 442, 414, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
560, 3el3A, 0.8329, 2.75, 0.204, 417, 406, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
561, 2pg6B, 0.8326, 3.51, 0.193, 464, 425, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
562, 5vbuB, 0.8325, 3.15, 0.203, 441, 413, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
563, 2fdvB, 0.8325, 3.55, 0.194, 465, 427, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
564, 5uysC, 0.8324, 3.41, 0.216, 473, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
565, 4nkyA, 0.8324, 3.42, 0.220, 462, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
566, 6chiC, 0.8323, 3.40, 0.216, 476, 421, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
567, 3tmzA, 0.8323, 3.47, 0.172, 463, 424, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH AMLODIPINE
568, 5irvC, 0.8322, 3.40, 0.216, 475, 421, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
569, 4wnvB, 0.8322, 3.10, 0.175, 455, 411, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
570, 4wnuC, 0.8322, 3.09, 0.170, 452, 411, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
571, 3tbgB, 0.8321, 3.13, 0.175, 456, 412, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
572, 4wnuA, 0.8320, 3.05, 0.168, 449, 410, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
573, 4gqsC, 0.8320, 3.42, 0.188, 462, 425, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
574, 5uysD, 0.8319, 3.36, 0.214, 473, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
575, 4nkxA, 0.8319, 3.40, 0.218, 466, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
576, 4nkvC, 0.8318, 3.41, 0.216, 471, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
577, 3rukD, 0.8318, 3.37, 0.211, 473, 421, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
578, 1og5A, 0.8318, 3.31, 0.188, 461, 420, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
579, 6cizC, 0.8317, 3.41, 0.216, 477, 421, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
580, 1og2B, 0.8317, 3.32, 0.188, 461, 420, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
581, 6cirB, 0.8316, 3.42, 0.218, 466, 422, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
582, 3rukB, 0.8316, 3.43, 0.218, 465, 422, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
583, 3danA, 0.8316, 3.25, 0.134, 473, 419, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
584, 5tfuB, 0.8315, 3.13, 0.170, 451, 412, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
585, 3tdaB, 0.8315, 3.17, 0.175, 456, 412, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
586, 3tbgD, 0.8311, 3.15, 0.175, 456, 412, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
587, 5irqC, 0.8310, 3.43, 0.216, 472, 421, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
588, 1og5B, 0.8309, 3.32, 0.190, 461, 420, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
589, 3rukA, 0.8308, 3.46, 0.218, 464, 422, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
590, 2pg5B, 0.8308, 3.56, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
591, 4xrzC, 0.8307, 3.22, 0.171, 455, 414, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
592, 3tdaD, 0.8306, 3.18, 0.180, 456, 412, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
593, 5xxiA, 0.8305, 3.52, 0.192, 463, 427, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
594, 5irvD, 0.8305, 3.36, 0.217, 472, 420, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
595, 4y8wB, 0.8305, 3.16, 0.204, 440, 412, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
596, 4wntB, 0.8305, 3.15, 0.175, 455, 411, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
597, 4nkyB, 0.8305, 3.44, 0.220, 464, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
598, 5x24A, 0.8304, 3.45, 0.192, 463, 426, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT I359L (*3) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
599, 5iuzB, 0.8304, 3.59, 0.173, 464, 427, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
600, 5x23A, 0.8303, 3.49, 0.195, 463, 426, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT A477T (*30) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
601, 6cizD, 0.8302, 3.45, 0.216, 468, 421, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
602, 6cirC, 0.8302, 3.43, 0.214, 472, 421, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
603, 3swzB, 0.8301, 3.44, 0.216, 465, 422, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
604, 3kswA, 0.8301, 3.05, 0.164, 444, 414, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH AN INHIBITOR VNF ((4-(4- CHLOROPHENYL)-N-[2-(1H-IMIDAZOL-1-YL)-1-PHENYLETHYL]BENZAMIDE)
605, 4nkzB, 0.8300, 3.35, 0.219, 461, 420, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
606, 3damA, 0.8299, 3.19, 0.137, 467, 417, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
607, 2fdyC, 0.8299, 3.51, 0.195, 464, 425, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
608, 3dbmA, 0.8298, 3.21, 0.141, 467, 417, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
609, 3t3rD, 0.8297, 3.52, 0.189, 464, 424, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
610, 4xrzD, 0.8295, 3.24, 0.171, 455, 414, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
611, 4nkzA, 0.8294, 3.39, 0.219, 463, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
612, 3swzC, 0.8294, 3.43, 0.216, 470, 421, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
613, 3kw4A, 0.8294, 3.58, 0.171, 466, 427, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG TICLOPIDINE
614, 2pg5C, 0.8293, 3.50, 0.195, 463, 425, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
615, 2fdwC, 0.8293, 3.54, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
616, 2fdvC, 0.8293, 3.53, 0.195, 464, 426, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
617, 2fduC, 0.8292, 3.54, 0.195, 464, 426, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
618, 6chiD, 0.8291, 3.47, 0.216, 467, 421, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
619, 2pg6C, 0.8291, 3.55, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
620, 2fduB, 0.8291, 3.55, 0.195, 463, 425, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
621, 1z11A, 0.8291, 3.65, 0.200, 467, 429, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
622, 5tfuA, 0.8290, 3.11, 0.171, 451, 410, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
623, 3cliA, 0.8290, 3.22, 0.129, 465, 417, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
624, 1z11C, 0.8290, 3.49, 0.191, 464, 425, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
625, 3dsjA, 0.8289, 3.22, 0.129, 465, 417, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
626, 3dsiA, 0.8289, 3.22, 0.129, 466, 417, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
627, 1z10C, 0.8289, 3.54, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
628, 1og2A, 0.8289, 3.35, 0.189, 461, 419, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
629, 6cirD, 0.8288, 3.37, 0.214, 471, 420, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
630, 4wnvD, 0.8288, 3.09, 0.176, 453, 409, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
631, 2rcmA, 0.8288, 3.22, 0.129, 465, 417, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
632, 4nkyC, 0.8286, 3.34, 0.215, 467, 419, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
633, 2rclA, 0.8286, 3.23, 0.129, 465, 417, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
634, 2rchA, 0.8286, 3.22, 0.129, 465, 417, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
635, 5tftD, 0.8285, 3.11, 0.178, 453, 409, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
636, 3uasA, 0.8285, 3.45, 0.173, 461, 423, CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR 9-ETHYNYLPHENANTHRENE
637, 3dskA, 0.8281, 3.23, 0.129, 466, 417, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
638, 3me6B, 0.8280, 3.53, 0.172, 465, 425, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
639, 4nkwD, 0.8279, 3.47, 0.216, 467, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
640, 3t3qC, 0.8278, 3.55, 0.196, 463, 424, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
641, 3qz1A, 0.8278, 3.15, 0.174, 445, 413, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
642, 3rukC, 0.8277, 3.43, 0.211, 472, 421, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
643, 3me6C, 0.8277, 3.53, 0.172, 465, 425, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
644, 4nkvD, 0.8275, 3.49, 0.216, 466, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
645, 3me6D, 0.8274, 3.53, 0.172, 465, 425, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
646, 2pg7C, 0.8274, 3.58, 0.192, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
647, 4xryD, 0.8273, 3.22, 0.172, 452, 412, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
648, 3me6A, 0.8273, 3.53, 0.172, 465, 425, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
649, 5iuzA, 0.8272, 3.54, 0.172, 459, 424, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
650, 3tk3D, 0.8272, 3.54, 0.172, 465, 425, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
651, 3mvrA, 0.8272, 3.64, 0.171, 463, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
652, 3ebsC, 0.8272, 3.59, 0.195, 464, 426, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
653, 5iutA, 0.8271, 3.52, 0.170, 460, 424, STRUCTURE OF P450 2B4 F202W MUTANT
654, 4wnuB, 0.8271, 3.12, 0.174, 453, 409, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
655, 4nkxC, 0.8271, 3.49, 0.214, 469, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
656, 4nkwC, 0.8271, 3.43, 0.217, 467, 420, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
657, 3tk3C, 0.8270, 3.63, 0.173, 465, 427, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
658, 3mvrB, 0.8270, 3.65, 0.171, 463, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
659, 3tk3A, 0.8269, 3.62, 0.173, 465, 427, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
660, 5irqD, 0.8267, 3.51, 0.216, 465, 421, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
661, 3tk3B, 0.8267, 3.58, 0.174, 465, 426, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
662, 4jltA, 0.8266, 3.51, 0.173, 458, 423, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH PAROXETINE
663, 3t3qD, 0.8266, 3.54, 0.196, 463, 424, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
664, 3t3rA, 0.8265, 3.54, 0.195, 463, 425, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
665, 5tfuD, 0.8264, 3.26, 0.172, 453, 413, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
666, 5tfuC, 0.8262, 3.11, 0.179, 450, 408, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
667, 4wnuD, 0.8262, 3.12, 0.176, 450, 408, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
668, 2fduD, 0.8262, 3.61, 0.195, 464, 426, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
669, 5em4B, 0.8261, 3.62, 0.171, 459, 426, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
670, 5em4A, 0.8261, 3.62, 0.171, 460, 426, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
671, 2fdvA, 0.8261, 3.63, 0.201, 465, 427, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
672, 2fduA, 0.8261, 3.63, 0.201, 465, 427, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
673, 1z11D, 0.8260, 3.60, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
674, 1r9oA, 0.8257, 3.40, 0.187, 455, 418, CRYSTAL STRUCTURE OF P4502C9 WITH FLURBIPROFEN BOUND
675, 2f9qC, 0.8255, 3.20, 0.178, 454, 410, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
676, 2fdwD, 0.8254, 3.62, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
677, 1z10D, 0.8254, 3.62, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
678, 4h1nA, 0.8251, 3.61, 0.174, 459, 425, CRYSTAL STRUCTURE OF P450 2B4 F297A MUTANT IN COMPLEX WITH ANTI- PLATELET DRUG CLOPIDOGREL
679, 3t3qB, 0.8251, 3.60, 0.195, 463, 425, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
680, 2pg5D, 0.8251, 3.62, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
681, 5a5iA, 0.8250, 3.36, 0.185, 453, 416, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
682, 2fdyB, 0.8250, 3.58, 0.191, 464, 424, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
683, 4ejjC, 0.8249, 3.62, 0.195, 464, 426, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
684, 1z10A, 0.8249, 3.65, 0.201, 465, 427, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
685, 4ruiF, 0.8247, 3.65, 0.194, 465, 427, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
686, 3swzD, 0.8247, 3.47, 0.214, 466, 420, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
687, 2f9qA, 0.8247, 3.21, 0.178, 454, 410, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
688, 5a5jA, 0.8246, 3.43, 0.184, 455, 418, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
689, 2pg6D, 0.8246, 3.64, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
690, 4ruiE, 0.8243, 3.65, 0.194, 465, 427, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
691, 4ruiD, 0.8243, 3.66, 0.194, 465, 427, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
692, 4r21B, 0.8243, 2.92, 0.223, 423, 403, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
693, 4nkxD, 0.8243, 3.46, 0.214, 468, 420, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
694, 2pg7A, 0.8243, 3.66, 0.192, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
695, 2q6nB, 0.8242, 3.63, 0.174, 465, 426, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
696, 2pg5A, 0.8242, 3.65, 0.195, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
697, 4nkyD, 0.8241, 3.48, 0.217, 465, 420, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
698, 5k7kA, 0.8239, 3.47, 0.189, 455, 419, DESIGN AND OPTIMIZATION OF BIARYL ETHER ARYL SULFONAMIDES AS SELECTIVE INHIBITORS OF NAV1.7: DISCOVERY OF CLINICAL CANDIDATE PF-05089771
699, 4ruiB, 0.8239, 3.70, 0.199, 465, 428, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
700, 4ejjB, 0.8239, 3.64, 0.195, 464, 426, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
701, 2pg6A, 0.8239, 3.68, 0.201, 465, 427, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
702, 2fdwA, 0.8238, 3.68, 0.201, 465, 427, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
703, 4nkzC, 0.8237, 3.43, 0.217, 464, 419, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
704, 3ebsA, 0.8237, 3.67, 0.201, 465, 427, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
705, 2q6nG, 0.8237, 3.64, 0.174, 465, 426, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
706, 5wbgB, 0.8236, 3.63, 0.174, 464, 426, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
707, 4ejjA, 0.8236, 3.64, 0.195, 465, 426, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
708, 4r21A, 0.8235, 2.89, 0.221, 422, 402, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
709, 3ebsD, 0.8235, 3.65, 0.195, 464, 426, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
710, 2fdvD, 0.8233, 3.66, 0.195, 464, 426, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
711, 4ejhA, 0.8232, 3.63, 0.197, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
712, 3qz1C, 0.8231, 3.10, 0.198, 437, 409, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
713, 2vkuA, 0.8231, 3.18, 0.202, 444, 411, 44 -DIHYDROXYBENZOPHENONE MIMICS STEROL SUBSTRATE IN THE BINDING SITE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) IN THE X-RAY STRUCTURE OF THE COMPLEX
714, 4ejjD, 0.8230, 3.65, 0.195, 464, 426, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
715, 4ruiC, 0.8229, 3.65, 0.195, 464, 426, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
716, 2pg7D, 0.8229, 3.65, 0.192, 464, 426, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
717, 5wbgF, 0.8228, 3.64, 0.176, 464, 426, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
718, 5wbgC, 0.8228, 3.64, 0.174, 464, 426, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
719, 4ruiA, 0.8228, 3.63, 0.197, 464, 426, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
720, 4nkzD, 0.8227, 3.50, 0.217, 465, 420, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
721, 4ejgE, 0.8227, 3.64, 0.204, 465, 427, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
722, 3t3sB, 0.8226, 3.66, 0.200, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
723, 3r1aA, 0.8226, 3.69, 0.171, 465, 427, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
724, 4ejhC, 0.8225, 3.67, 0.204, 464, 427, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
725, 4ejgD, 0.8224, 3.66, 0.204, 465, 427, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
726, 4ejgC, 0.8224, 3.64, 0.200, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
727, 3t3rB, 0.8224, 3.62, 0.195, 463, 425, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
728, 4ejgA, 0.8223, 3.66, 0.200, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
729, 3qz1B, 0.8221, 3.05, 0.194, 436, 408, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
730, 3t3qA, 0.8220, 3.64, 0.195, 463, 425, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
731, 3qu8A, 0.8219, 3.64, 0.174, 462, 426, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
732, 3t3sD, 0.8217, 3.71, 0.204, 464, 427, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
733, 3t3rC, 0.8217, 3.64, 0.195, 463, 425, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
734, 3pm0A, 0.8217, 3.15, 0.177, 459, 412, STRUCTURAL CHARACTERIZATION OF THE COMPLEX BETWEEN ALPHA- NAPHTHOFLAVONE AND HUMAN CYTOCHROME P450 1B1 (CYP1B1)
735, 2fdyA, 0.8217, 3.67, 0.195, 465, 426, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
736, 5wbgD, 0.8216, 3.61, 0.176, 464, 425, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
737, 5tftC, 0.8216, 3.08, 0.178, 447, 405, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
738, 4ejhD, 0.8216, 3.69, 0.204, 464, 427, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
739, 4ejgB, 0.8216, 3.66, 0.200, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
740, 4ejhB, 0.8215, 3.69, 0.201, 464, 427, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
741, 5wbgA, 0.8214, 3.67, 0.174, 463, 426, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
742, 4ejhE, 0.8213, 3.70, 0.201, 464, 427, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
743, 4ejgF, 0.8212, 3.69, 0.204, 465, 427, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
744, 3r1aD, 0.8212, 3.74, 0.176, 465, 427, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
745, 5e58D, 0.8211, 3.73, 0.194, 463, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
746, 3t3sC, 0.8211, 3.61, 0.198, 464, 425, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
747, 5wbgE, 0.8209, 3.68, 0.171, 463, 426, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
748, 3r1aC, 0.8209, 3.72, 0.169, 465, 427, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
749, 2fdyD, 0.8209, 3.69, 0.195, 464, 426, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
750, 3t3sA, 0.8208, 3.67, 0.198, 464, 425, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
751, 2q6nF, 0.8208, 3.81, 0.175, 465, 428, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
752, 5e58A, 0.8206, 3.74, 0.194, 464, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
753, 4xryC, 0.8205, 3.20, 0.172, 446, 408, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
754, 4ejhF, 0.8204, 3.69, 0.200, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
755, 2q6nC, 0.8204, 3.78, 0.175, 465, 428, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
756, 3r1aG, 0.8203, 3.73, 0.171, 465, 427, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
757, 2p85E, 0.8203, 3.67, 0.195, 464, 425, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
758, 2f9qB, 0.8203, 3.17, 0.179, 451, 407, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
759, 3qu8C, 0.8202, 3.67, 0.174, 462, 426, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
760, 3t3sH, 0.8201, 3.60, 0.196, 464, 423, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
761, 5e58C, 0.8199, 3.78, 0.194, 465, 428, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
762, 3b6hB, 0.8198, 3.43, 0.169, 470, 419, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
763, 2f9qD, 0.8195, 3.20, 0.179, 451, 407, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
764, 3t3sG, 0.8193, 3.70, 0.200, 464, 426, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
765, 3qz1D, 0.8192, 3.04, 0.192, 434, 406, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
766, 3t3sF, 0.8190, 3.64, 0.198, 464, 424, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
767, 3kohB, 0.8189, 3.64, 0.179, 463, 425, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
768, 4ejiA, 0.8187, 3.68, 0.200, 464, 425, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH TWO MOLECULES OF 4- (METHYLNITROSAMINO)-1-(3-PURIDYL)-1-BUTANONE
769, 2q6nA, 0.8187, 3.68, 0.172, 465, 425, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
770, 4zv8A, 0.8184, 3.79, 0.175, 465, 428, STRUCTURE OF CYP2B6 (Y226H/K262R) WITH ADDITIONAL MUTATION Y244W IN COMPLEX WITH ALPHA-PINENE
771, 4mgjA, 0.8184, 3.47, 0.173, 452, 416, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 F429H IN COMPLEX WITH 4-CPI
772, 3r1aF, 0.8182, 3.80, 0.173, 465, 428, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
773, 2rcmB, 0.8182, 3.37, 0.130, 465, 414, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
774, 4rqlB, 0.8180, 3.80, 0.175, 465, 428, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
775, 5e58E, 0.8178, 3.79, 0.194, 462, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
776, 2rclB, 0.8178, 3.32, 0.136, 465, 413, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
777, 4rqlA, 0.8177, 3.80, 0.175, 465, 428, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
778, 4i91A, 0.8177, 3.80, 0.175, 465, 428, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH ALPHA-PINENE.
779, 3kohA, 0.8176, 3.72, 0.185, 463, 427, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
780, 3cliB, 0.8176, 3.34, 0.136, 465, 413, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
781, 2p85F, 0.8176, 3.73, 0.204, 464, 426, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
782, 2p85D, 0.8176, 3.74, 0.202, 464, 426, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
783, 2p85A, 0.8176, 3.69, 0.198, 464, 425, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
784, 5uecA, 0.8174, 3.75, 0.173, 465, 427, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH MYRTENYL BROMIDE.
785, 3qu8B, 0.8174, 3.62, 0.175, 459, 423, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
786, 3r1aH, 0.8173, 3.76, 0.178, 464, 426, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
787, 3e4eB, 0.8173, 3.67, 0.188, 461, 425, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
788, 3r1aE, 0.8172, 3.83, 0.175, 465, 428, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
789, 3qu8E, 0.8172, 3.63, 0.177, 459, 423, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
790, 3e4eA, 0.8172, 3.67, 0.188, 461, 425, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
791, 3dsjB, 0.8170, 3.35, 0.136, 465, 413, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
792, 3lc4A, 0.8169, 3.62, 0.189, 460, 423, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
793, 3dsiB, 0.8169, 3.35, 0.136, 465, 413, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
794, 3e6iB, 0.8168, 3.69, 0.188, 461, 425, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
795, 3e6iA, 0.8166, 3.70, 0.188, 462, 425, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
796, 2rchB, 0.8166, 3.36, 0.136, 465, 413, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
797, 2q6nD, 0.8166, 3.73, 0.171, 465, 426, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
798, 3qoaA, 0.8165, 3.72, 0.176, 460, 425, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-BENZYLPYRIDINE.
799, 2p85C, 0.8165, 3.78, 0.204, 464, 427, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
800, 2q6nE, 0.8163, 3.85, 0.178, 465, 428, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
801, 5udaA, 0.8160, 3.76, 0.176, 461, 426, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
802, 5uapB, 0.8160, 3.80, 0.176, 463, 427, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
803, 5e58B, 0.8160, 3.68, 0.194, 458, 423, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
804, 3dskB, 0.8160, 3.37, 0.136, 465, 413, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
805, 4gqsD, 0.8158, 3.45, 0.192, 452, 417, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
806, 4rrtA, 0.8157, 3.72, 0.176, 461, 425, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
807, 3gphB, 0.8156, 3.65, 0.186, 461, 424, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
808, 3t3zA, 0.8154, 3.70, 0.187, 464, 427, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
809, 2iagB, 0.8154, 3.49, 0.165, 468, 418, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
810, 5ufgA, 0.8153, 3.75, 0.176, 464, 426, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R/I114V) IN COMPLEX WITH MYRTENYL BROMIDE
811, 4rrtB, 0.8152, 3.78, 0.176, 461, 426, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
812, 3r1aB, 0.8152, 3.79, 0.173, 465, 427, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
813, 5uapA, 0.8151, 3.81, 0.176, 464, 427, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
814, 3t3zB, 0.8151, 3.71, 0.187, 464, 427, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
815, 3gphA, 0.8151, 3.67, 0.186, 461, 424, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
816, 3lc4B, 0.8150, 3.61, 0.190, 459, 422, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
817, 3qu8D, 0.8145, 3.63, 0.175, 458, 422, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
818, 4r20B, 0.8144, 2.85, 0.229, 414, 397, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
819, 3t3sE, 0.8144, 3.68, 0.200, 464, 424, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
820, 3b6hA, 0.8142, 3.54, 0.172, 469, 419, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
821, 2iagA, 0.8139, 3.60, 0.171, 471, 422, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
822, 5udaB, 0.8136, 3.77, 0.176, 460, 425, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
823, 3t3zC, 0.8132, 3.78, 0.183, 464, 427, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
824, 3t3zD, 0.8128, 3.74, 0.185, 464, 427, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
825, 5w0cA, 0.8123, 3.26, 0.189, 464, 407, CYTOCHROME P450 (CYP) 2C9 TCA007 INHIBITOR COMPLEX
826, 3v8dA, 0.8119, 3.88, 0.155, 479, 425, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
827, 3daxA, 0.8106, 3.68, 0.160, 472, 418, CRYSTAL STRUCTURE OF HUMAN CYP7A1
828, 5e58F, 0.8104, 3.78, 0.201, 457, 423, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
829, 1e9xA, 0.8100, 3.36, 0.196, 449, 408, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4-PHENYLIMIDAZOLE
830, 3sn5A, 0.8095, 3.62, 0.157, 468, 420, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
831, 2w0bA, 0.8086, 3.36, 0.199, 440, 407, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR 3-{[(4- METHYLPHENYL)SULFONYL]AMINO}PROPYL PYRIDIN-4-YLCARBAMATE
832, 1ea1A, 0.8083, 3.46, 0.196, 447, 409, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH FLUCONAZOLE
833, 4r20A, 0.8078, 2.83, 0.226, 406, 393, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
834, 3sn5B, 0.8074, 3.53, 0.156, 466, 416, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
835, 3daxB, 0.8054, 3.72, 0.156, 470, 417, CRYSTAL STRUCTURE OF HUMAN CYP7A1
836, 3qu8F, 0.8050, 3.64, 0.180, 453, 417, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
837, 5m0pA, 0.8045, 3.24, 0.135, 424, 406, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
838, 5m0pB, 0.8041, 3.20, 0.134, 421, 404, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
839, 5m0oC, 0.8034, 3.25, 0.135, 421, 406, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
840, 3v8dB, 0.8029, 3.86, 0.157, 467, 420, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
841, 5m0nA, 0.8026, 3.27, 0.138, 423, 406, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET IN COMPLEX WITH FORMATE
842, 2bz9B, 0.8024, 3.16, 0.195, 432, 401, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
843, 1x8vA, 0.8021, 3.23, 0.197, 429, 402, ESTRIOL-BOUND AND LIGAND-FREE STRUCTURES OF STEROL 14ALPHA- DEMETHYLASE (CYP51)
844, 1u13A, 0.8020, 3.22, 0.190, 433, 401, CRYSTAL STRUCTURE ANALYSIS OF THE C37L/C151T/C442A-TRIPLE MUTANT OF CYP51 FROM MYCOBACTERIUM TUBERCULOSIS
845, 1h5zA, 0.7971, 3.34, 0.195, 434, 401, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN FERRIC LOW-SPIN STATE
846, 5m0oA, 0.7965, 3.26, 0.134, 419, 402, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
847, 4l54A, 0.7962, 3.26, 0.137, 419, 402, STRUCTURE OF CYTOCHROME P450 OLET LIGAND-FREE
848, 4l40A, 0.7957, 3.26, 0.137, 419, 402, STRUCTURE OF THE P450 OLET WITH A C20 FATTY ACID SUBSTRATE BOUND
849, 2bz9A, 0.7957, 3.14, 0.196, 429, 397, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
850, 3r1bA, 0.7939, 3.74, 0.185, 465, 411, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
851, 2w09A, 0.7912, 3.21, 0.199, 421, 396, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR CIS-4- METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4- YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE
852, 4r1zA, 0.7911, 2.96, 0.210, 417, 386, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
853, 3r1bB, 0.7908, 3.86, 0.182, 465, 411, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
854, 5yhjB, 0.7899, 3.18, 0.126, 411, 397, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
855, 2w0aA, 0.7884, 3.23, 0.192, 424, 395, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR N-[(1S)-2-METHYL-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL] CYCLOHEXANECARBOXAMIDE
856, 4r1zB, 0.7878, 2.93, 0.211, 411, 384, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
857, 3r1bC, 0.7870, 3.86, 0.187, 456, 412, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
858, 2zqjB, 0.7870, 3.20, 0.151, 411, 397, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
859, 3g5nA, 0.7866, 3.85, 0.172, 456, 408, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
860, 2zqxC, 0.7865, 3.21, 0.156, 411, 397, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
861, 2zqjC, 0.7865, 3.22, 0.156, 411, 397, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
862, 2zqjA, 0.7858, 3.22, 0.151, 411, 397, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
863, 2zqxB, 0.7856, 3.22, 0.151, 411, 397, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
864, 1n97A, 0.7856, 2.44, 0.241, 385, 374, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
865, 2zqxA, 0.7855, 3.22, 0.151, 411, 397, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
866, 1izoB, 0.7853, 3.22, 0.154, 411, 397, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
867, 1izoC, 0.7845, 3.24, 0.156, 411, 397, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
868, 1izoA, 0.7842, 3.35, 0.151, 411, 398, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
869, 3r1bD, 0.7841, 4.00, 0.174, 464, 414, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
870, 5yhjA, 0.7837, 3.14, 0.127, 406, 393, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
871, 3b99A, 0.7830, 3.63, 0.167, 445, 408, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
872, 3g5nC, 0.7828, 3.77, 0.170, 452, 405, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
873, 3b98A, 0.7827, 3.62, 0.167, 446, 408, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
874, 3g5nB, 0.7825, 3.84, 0.175, 451, 406, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
875, 3g5nD, 0.7823, 3.84, 0.172, 451, 406, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
876, 3g93A, 0.7820, 3.77, 0.183, 454, 405, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
877, 5omsA, 0.7818, 2.93, 0.144, 403, 383, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAETHOL. 
878, 5omrA, 0.7815, 2.94, 0.144, 403, 383, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH VANILLIN. 
879, 2ci0A, 0.7812, 3.17, 0.195, 421, 390, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
880, 2cibA, 0.7803, 3.18, 0.203, 419, 390, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
881, 1po5A, 0.7797, 4.19, 0.169, 465, 414, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4
882, 5omuA, 0.7796, 2.94, 0.141, 402, 382, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH SYRINGOL 
883, 1n97B, 0.7784, 2.65, 0.241, 385, 374, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
884, 3vooA, 0.7748, 3.34, 0.132, 407, 394, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245E
885, 3tktA, 0.7748, 3.12, 0.174, 411, 386, CRYSTAL STRUCTURE OF CYP108D1 FROM NOVOSPHINGOBIUM AROMATICIVORANS DSM12444
886, 3vnoA, 0.7745, 3.36, 0.129, 407, 394, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT R241E
887, 3vm4A, 0.7744, 3.33, 0.132, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) IN COMPLEX WITH (R)-IBUPROPHEN
888, 3awqA, 0.7738, 3.34, 0.132, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT L78F
889, 3dbgB, 0.7735, 2.55, 0.218, 379, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 170A1 (CYP170A1) FROM STREPTOMYCES COELICOLOR
890, 3dbgA, 0.7735, 2.55, 0.218, 379, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 170A1 (CYP170A1) FROM STREPTOMYCES COELICOLOR
891, 3awmA, 0.7735, 3.35, 0.132, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) WILD-TYPE WITH PALMITIC ACID
892, 3vtjA, 0.7732, 3.33, 0.130, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245H
893, 2wm4A, 0.7730, 3.21, 0.160, 426, 387, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124 IN COMPLEX WITH PHYTANIC ACID
894, 3awpA, 0.7728, 3.36, 0.132, 407, 393, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT F288G
895, 2xkrA, 0.7726, 2.90, 0.171, 395, 381, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP142: A NOVEL CHOLESTEROL OXIDASE
896, 1cptA, 0.7715, 3.21, 0.182, 412, 385, CRYSTAL STRUCTURE AND REFINEMENT OF CYTOCHROME P450-TERP AT 2.3 ANGSTROMS RESOLUTION
897, 3g93B, 0.7701, 3.67, 0.182, 442, 396, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
898, 5fygB, 0.7680, 3.23, 0.135, 419, 385, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
899, 5ncbA, 0.7676, 2.85, 0.141, 396, 375, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAIACOL. 
900, 2wm5A, 0.7673, 3.53, 0.159, 425, 390, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124
901, 5fygA, 0.7670, 3.31, 0.132, 422, 386, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
902, 1xqdA, 0.7664, 3.02, 0.130, 399, 378, CRYSTAL STRUCTURE OF P450NOR COMPLEXED WITH 3- PYRIDINEALDEHYDE ADENINE DINUCLEOTIDE
903, 6bldA, 0.7661, 3.20, 0.135, 414, 385, MYCOBACTERIUM MARINUM CYTOCHROME P450 CYP268A2 IN COMPLEX WITH PSEUDOIONONE
904, 4triB, 0.7656, 3.18, 0.154, 400, 384, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
905, 4ep6A, 0.7653, 3.28, 0.148, 392, 384, CRYSTAL STRUCTURE OF THE XPLA HEME DOMAIN IN COMPLEX WITH IMIDAZOLE AND PEG
906, 4uaxA, 0.7650, 3.20, 0.156, 401, 384, X-RAY CRYSTAL STRUCTURE OF LIGAND FREE CYP142A2 FROM MYCOBACTERIUM SMEGMATIS
907, 4jbtB, 0.7650, 3.35, 0.153, 407, 385, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
908, 1egyA, 0.7650, 3.13, 0.152, 403, 382, CYTOCHROME P450ERYF WITH 9-AMINOPHENANTHRENE BOUND
909, 5fyfA, 0.7649, 3.30, 0.132, 420, 385, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
910, 4j6cB, 0.7648, 3.30, 0.151, 406, 384, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
911, 4jbtA, 0.7647, 3.35, 0.153, 407, 385, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
912, 1eupA, 0.7646, 3.14, 0.152, 403, 382, X-RAY CRYSTAL STRUCTURE OF CYTOCHROME P450ERYF WITH ANDROSTENDIONE BOUND
913, 4j6cA, 0.7645, 3.30, 0.154, 407, 384, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
914, 2wiyA, 0.7642, 3.38, 0.145, 394, 386, CYTOCHROME P450 XPLA HEME DOMAIN P21212
915, 4j6dB, 0.7641, 3.32, 0.151, 406, 384, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
916, 2yooC, 0.7639, 3.07, 0.157, 395, 382, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
917, 6giiA, 0.7638, 3.63, 0.113, 416, 391, THE CRYSTAL STRUCTURE OF TEPIDIPHILUS THERMOPHILUS P450 HEME DOMAIN 
918, 4j6dA, 0.7636, 3.34, 0.156, 406, 384, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
919, 1oxaA, 0.7635, 3.14, 0.152, 403, 382, CYTOCHROME P450 (DONOR:O2 OXIDOREDUCTASE)
920, 4triA, 0.7634, 3.04, 0.157, 401, 381, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
921, 2wivB, 0.7633, 3.24, 0.146, 391, 383, CYTOCHROME-P450 XPLA HEME DOMAIN P21
922, 2bdmA, 0.7633, 4.16, 0.175, 465, 406, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND BIFONAZOLE
923, 1jinA, 0.7632, 3.16, 0.154, 403, 382, P450ERYF/KETOCONAZOLE
924, 4j6bB, 0.7628, 3.25, 0.152, 405, 382, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
925, 4j6bA, 0.7628, 3.32, 0.151, 405, 383, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
926, 1jipA, 0.7628, 3.20, 0.157, 403, 383, P450ERYF(A245S)/KETOCONAZOLE
927, 4pxhA, 0.7627, 3.60, 0.172, 417, 390, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
928, 3zbyA, 0.7627, 3.25, 0.154, 402, 384, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
929, 3zbyF, 0.7626, 3.25, 0.154, 402, 384, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
930, 3zbyD, 0.7626, 3.25, 0.154, 402, 384, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
931, 3zbyC, 0.7625, 3.26, 0.154, 402, 384, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
932, 3zbyB, 0.7625, 3.25, 0.154, 404, 384, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
933, 3zbyE, 0.7623, 3.26, 0.154, 402, 384, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
934, 3be0A, 0.7623, 3.26, 0.133, 397, 384, THE ROLE OF ASN 242 IN P450CIN
935, 3bdzB, 0.7622, 3.27, 0.135, 397, 384, THE ROLE OF ASN 242 IN P450CIN
936, 2wivA, 0.7621, 3.25, 0.146, 391, 383, CYTOCHROME-P450 XPLA HEME DOMAIN P21
937, 3g93D, 0.7620, 3.82, 0.179, 440, 396, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
938, 4pxhE, 0.7619, 3.52, 0.170, 407, 388, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
939, 2yooB, 0.7619, 3.06, 0.157, 395, 381, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
940, 1jioA, 0.7618, 3.32, 0.154, 403, 384, P450ERYF/6DEB
941, 3be0B, 0.7616, 3.27, 0.130, 397, 384, THE ROLE OF ASN 242 IN P450CIN
942, 1z8qA, 0.7616, 3.17, 0.157, 403, 382, FERROUS DIOXYGEN COMPLEX OF THE A245T CYTOCHROME P450ERYF
943, 3a1lA, 0.7615, 3.31, 0.185, 411, 383, CRYSTAL STRUCTURE OF 1111 -DICHLOROCHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
944, 1z8pA, 0.7615, 3.17, 0.154, 403, 382, FERROUS DIOXYGEN COMPLEX OF THE A245S CYTOCHROME P450ERYF
945, 1z8oA, 0.7612, 3.14, 0.155, 402, 381, FERROUS DIOXYGEN COMPLEX OF THE WILD-TYPE CYTOCHROME P450ERYF
946, 2yooA, 0.7611, 3.07, 0.157, 396, 381, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
947, 4l77B, 0.7610, 3.24, 0.141, 397, 383, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
948, 2yooD, 0.7610, 3.04, 0.158, 394, 380, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
949, 4l77A, 0.7606, 3.22, 0.134, 396, 382, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
950, 4pxhC, 0.7605, 3.58, 0.167, 409, 389, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
951, 3p3xA, 0.7605, 3.20, 0.176, 397, 380, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
952, 3bdzA, 0.7604, 3.30, 0.135, 397, 384, THE ROLE OF ASN 242 IN P450CIN
953, 4fmxA, 0.7599, 3.31, 0.135, 397, 384, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
954, 3g93C, 0.7597, 3.84, 0.177, 442, 395, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
955, 2x5wA, 0.7595, 3.24, 0.144, 409, 382, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH SUBSTRATE CHOLEST-4-EN-3-ONE
956, 4lhtA, 0.7594, 3.32, 0.135, 396, 384, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
957, 2z3uA, 0.7593, 3.33, 0.188, 411, 383, CRYSTAL STRUCTURE OF CHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
958, 4fyzA, 0.7592, 3.31, 0.135, 397, 384, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
959, 4fmxB, 0.7592, 3.32, 0.135, 397, 384, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
960, 4lhtB, 0.7590, 3.32, 0.138, 396, 384, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
961, 3b98B, 0.7590, 3.70, 0.171, 427, 398, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
962, 1t2bA, 0.7590, 3.27, 0.138, 397, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
963, 4l6gB, 0.7589, 3.32, 0.135, 397, 384, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
964, 3p3xB, 0.7588, 3.23, 0.171, 399, 380, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
965, 1t2bB, 0.7586, 3.28, 0.138, 397, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
966, 4l6gA, 0.7585, 3.28, 0.138, 397, 383, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
967, 2fr7A, 0.7585, 3.42, 0.125, 397, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP199A2
968, 1wiyB, 0.7583, 2.24, 0.237, 362, 358, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
969, 4fyzB, 0.7578, 3.33, 0.138, 397, 384, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
970, 4mm0B, 0.7577, 3.26, 0.146, 394, 378, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
971, 1qmqA, 0.7577, 3.43, 0.158, 406, 385, OPTICAL DETECTION OF CYTOCHROME P450 BY SENSITIZER-LINKED SUBSTRATES
972, 4jx1F, 0.7574, 3.47, 0.150, 405, 386, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
973, 4l0fA, 0.7573, 3.46, 0.161, 437, 386, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (OPEN ACTIVE SITE)
974, 5gweC, 0.7571, 3.36, 0.173, 405, 382, CYTOCHROME P450 CREJ
975, 1ulwA, 0.7571, 3.35, 0.127, 399, 379, CRYSTAL STRUCTURE OF P450NOR SER73GLY/SER75GLY MUTANT
976, 2d0eA, 0.7570, 3.31, 0.147, 404, 382, SUBSTRATE ASSITED IN OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
977, 4mm0A, 0.7569, 3.18, 0.146, 392, 376, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
978, 1k2oB, 0.7569, 3.40, 0.161, 406, 385, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
979, 4jx1B, 0.7568, 3.49, 0.153, 405, 386, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
980, 3p3lB, 0.7564, 3.40, 0.173, 403, 382, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
981, 3abaA, 0.7564, 3.41, 0.173, 397, 381, CRYSTAL STRUCTURE OF CYP105P1 IN COMPLEX WITH FILIPIN I
982, 4jx1A, 0.7563, 3.46, 0.156, 405, 385, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
983, 4dnjA, 0.7561, 3.34, 0.126, 399, 382, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A2
984, 3p3lA, 0.7560, 3.41, 0.175, 403, 382, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
985, 1k2oA, 0.7560, 3.50, 0.155, 406, 386, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
986, 4dxyA, 0.7559, 3.46, 0.151, 406, 385, CRYSTAL STRUCTURES OF CYP101D2 Y96A MUTANT
987, 5gweA, 0.7558, 3.38, 0.173, 405, 382, CYTOCHROME P450 CREJ
988, 3nc6B, 0.7556, 3.08, 0.149, 389, 375, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
989, 4jwuA, 0.7553, 3.54, 0.158, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
990, 3p6sA, 0.7551, 3.51, 0.153, 404, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
991, 5xjnA, 0.7550, 3.34, 0.171, 403, 381, CYTOCHROME P450 CREJ IN COMPLEX WITH (4-ETHYLPHENYL) DIHYDROGEN PHOSPHATE
992, 3bujA, 0.7550, 3.18, 0.153, 397, 378, CRYSTAL STRUCTURE OF CALO2
993, 4egmB, 0.7549, 3.27, 0.137, 394, 380, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
994, 1gwiA, 0.7549, 3.29, 0.164, 402, 379, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
995, 1rf9A, 0.7548, 3.51, 0.158, 404, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-4-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-BUTYL-AMIDE)
996, 3cv9A, 0.7547, 3.19, 0.142, 401, 379, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R73A/R84A MUTANT) IN COMPLEX WITH 1ALPHA25- DIHYDROXYVITAMIN D3
997, 1romA, 0.7546, 3.33, 0.132, 399, 378, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM
998, 5foiA, 0.7544, 3.22, 0.152, 389, 375, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
999, 5ikiB, 0.7543, 3.20, 0.196, 399, 377, CYP106A2 WITH SUBSTRATE ABIETIC ACID
1000, 1odoA, 0.7543, 3.21, 0.180, 395, 377, 1.85 A STRUCTURE OF CYP154A1 FROM STREPTOMYCES COELICOLOR A3(2)
1001, 5fyfB, 0.7540, 3.19, 0.132, 411, 378, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
1002, 2romA, 0.7540, 3.33, 0.127, 399, 378, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM COMPLEX WITH CARBON MONOXIDE
1003, 5gweD, 0.7539, 3.37, 0.173, 403, 382, CYTOCHROME P450 CREJ
1004, 3p6uA, 0.7539, 3.37, 0.149, 402, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C6-DANS
1005, 3nv6A, 0.7538, 3.47, 0.146, 404, 384, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D2
1006, 5gxgA, 0.7537, 3.43, 0.162, 401, 382, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
1007, 5kdbA, 0.7536, 3.19, 0.138, 393, 378, THE CRYSTAL STRUCTURE OF 4-ISOPROPYLBENZOATE-BOUND CYP199A4
1008, 4egmA, 0.7536, 3.26, 0.135, 393, 379, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1009, 5y5mA, 0.7535, 3.40, 0.132, 399, 379, SFX STRUCTURE OF CYTOCHROME P450NOR: A COMPLETE DARK DATA WITHOUT PUMP LASER (RESTING STATE) 
1010, 4jwuB, 0.7535, 3.35, 0.157, 403, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
1011, 1geiA, 0.7535, 3.34, 0.127, 399, 378, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1012, 5y5lA, 0.7534, 3.40, 0.127, 399, 379, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
1013, 5u6uA, 0.7534, 3.19, 0.138, 393, 378, THE CRYSTAL STRUCTURE OF 4-ETHYLTHIOBENZOATE-BOUND CYP199A4 
1014, 5y5kA, 0.7533, 3.40, 0.132, 399, 379, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1015, 5y5jA, 0.7533, 3.40, 0.127, 399, 379, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
1016, 5y5iA, 0.7533, 3.40, 0.132, 399, 379, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1017, 2zbzA, 0.7533, 3.19, 0.143, 404, 378, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D3
1018, 5y5gA, 0.7532, 3.44, 0.126, 400, 380, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
1019, 1cmjA, 0.7532, 3.40, 0.127, 399, 379, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
1020, 4dnzC, 0.7531, 3.41, 0.138, 393, 383, THE CRYSTAL STRUCTURES OF CYP199A4
1021, 4dnzB, 0.7531, 3.27, 0.137, 393, 379, THE CRYSTAL STRUCTURES OF CYP199A4
1022, 5foiB, 0.7530, 3.22, 0.152, 388, 374, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
1023, 4jx1E, 0.7530, 3.47, 0.148, 405, 385, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
1024, 4egoC, 0.7530, 3.41, 0.141, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1025, 4do1A, 0.7530, 3.28, 0.135, 393, 379, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1026, 3w9cA, 0.7530, 3.45, 0.162, 401, 382, CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
1027, 3p3zA, 0.7530, 3.35, 0.179, 407, 380, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH FROM STREPTOMYCES THIOLUTEUS IN COMPLEX WITH ANCYMIDOL
1028, 1gejA, 0.7530, 3.34, 0.127, 399, 378, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1029, 1f25A, 0.7530, 3.40, 0.124, 399, 379, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ASN MUTANTS OF CYTOCHROME P450NOR
1030, 5y5lB, 0.7529, 3.40, 0.127, 399, 379, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
1031, 5y5jB, 0.7529, 3.40, 0.127, 399, 379, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
1032, 5y5hA, 0.7529, 3.44, 0.126, 400, 380, SF-ROX STRUCTURE OF CYTOCHROME P450NOR (NO-BOUND STATE) DETERMINED AT SACLA
1033, 5nwsA, 0.7529, 3.28, 0.167, 395, 378, CRYSTAL STRUCTURE OF SAACMM INVOLVED IN ACTINOMYCIN BIOSYNTHESIS
1034, 3p6tA, 0.7529, 3.46, 0.148, 404, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
1035, 5y5mB, 0.7528, 3.40, 0.127, 399, 379, SFX STRUCTURE OF CYTOCHROME P450NOR: A COMPLETE DARK DATA WITHOUT PUMP LASER (RESTING STATE) 
1036, 5y5kB, 0.7528, 3.40, 0.127, 399, 379, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1037, 5y5iB, 0.7528, 3.40, 0.127, 399, 379, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1038, 4egoB, 0.7528, 3.32, 0.132, 393, 380, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1039, 3wriB, 0.7528, 3.50, 0.159, 403, 383, CRYSTAL STRUCTURE OF P450CAM
1040, 3cv8A, 0.7528, 3.24, 0.142, 402, 379, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84F MUTANT)
1041, 2d09A, 0.7528, 3.42, 0.146, 404, 384, A ROLE FOR ACTIVE SITE WATER MOLECULES AND HYDROXYL GROUPS OF SUBSTRATE FOR OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
1042, 1jfcA, 0.7528, 3.40, 0.127, 399, 379, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERROUS CO STATE AT ATOMIC RESOLUTION
1043, 1jfbA, 0.7528, 3.40, 0.127, 399, 379, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERRIC RESTING STATE AT ATOMIC RESOLUTION
1044, 1f24A, 0.7528, 3.40, 0.124, 399, 379, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ALA MUTANTS OF CYTOCHROME P450NOR
1045, 4l0eA, 0.7527, 3.43, 0.162, 440, 383, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (HEME-COORDINATED EXPRESSION TAG)
1046, 4egoA, 0.7527, 3.28, 0.137, 393, 379, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1047, 3wriA, 0.7527, 3.50, 0.159, 403, 383, CRYSTAL STRUCTURE OF P450CAM
1048, 3p6qA, 0.7526, 3.49, 0.154, 401, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-ETG-BOC
1049, 3nv5A, 0.7526, 3.43, 0.147, 399, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D2
1050, 1f26A, 0.7526, 3.40, 0.124, 399, 379, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243VAL MUTANTS OF CYTOCHROME P450NOR
1051, 5x7eA, 0.7525, 3.21, 0.143, 404, 378, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D2
1052, 4egnC, 0.7525, 3.41, 0.138, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1053, 4egnB, 0.7525, 3.29, 0.135, 393, 379, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1054, 4egpA, 0.7524, 3.30, 0.135, 393, 379, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
1055, 1cl6A, 0.7524, 3.41, 0.127, 399, 379, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND ITS SER286 MUTANTS AT CRYOGENIC TEMPERATURE
1056, 5uvbA, 0.7523, 3.22, 0.140, 393, 378, THE CRYSTAL STRUCTURE OF 4-CYCLOPROPYLBENZOATE-BOUND CYP199A4
1057, 4egmC, 0.7522, 3.44, 0.135, 393, 384, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1058, 4dnzA, 0.7522, 3.29, 0.137, 393, 379, THE CRYSTAL STRUCTURES OF CYP199A4
1059, 1t93A, 0.7522, 3.36, 0.146, 403, 383, EVIDENCE FOR MULTIPLE SUBSTRATE RECOGNITION AND MOLECULAR MECHANISM OF C-C REACTION BY CYTOCHROME P450 CYP158A2 FROM STREPTOMYCES COELICOLOR A3(2)
1060, 1gedA, 0.7522, 3.41, 0.127, 399, 379, A POSITIVE CHARGE ROUTE FOR THE ACCESS OF NADH TO HEME FORMED IN THE DISTAL HEME POCKET OF CYTOCHROME P450NOR
1061, 5kdyA, 0.7521, 3.41, 0.133, 393, 383, THE CRYSTAL STRUCTURE OF THE D251N MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
1062, 4do1C, 0.7521, 3.38, 0.139, 393, 382, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1063, 1eheA, 0.7521, 3.42, 0.127, 399, 379, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1064, 4do1B, 0.7520, 3.29, 0.135, 393, 379, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1065, 1ehgA, 0.7520, 3.41, 0.127, 399, 379, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1066, 5u6tA, 0.7519, 3.41, 0.133, 393, 383, THE CRYSTAL STRUCTURE OF 4-ETHOXYBENZOATE-BOUND CYP199A4 
1067, 5kt1A, 0.7519, 3.41, 0.133, 393, 383, THE CRYSTAL STRUCTURE OF 4-METHYLTHIOBENZOATE-BOUND CYP199A4
1068, 1cmnA, 0.7519, 3.42, 0.127, 399, 379, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
1069, 5y1iB, 0.7518, 3.49, 0.135, 394, 378, THE CRYSTAL STRUCTURE OF GFSF
1070, 2z36A, 0.7518, 3.62, 0.162, 403, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
1071, 1re9A, 0.7518, 3.64, 0.147, 404, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
1072, 4egnA, 0.7517, 3.33, 0.134, 393, 380, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1073, 3p6oA, 0.7517, 3.50, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-ETG-DANS
1074, 1ehfA, 0.7515, 3.43, 0.127, 399, 379, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1075, 5u6wA, 0.7512, 3.43, 0.136, 393, 383, THE CRYSTAL STRUCTURE OF 4-METHYLAMINOBENZOATE-BOUND CYP199A4 
1076, 3ofuC, 0.7512, 3.51, 0.128, 396, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1077, 1gwiB, 0.7510, 3.30, 0.158, 400, 379, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
1078, 2z36B, 0.7509, 3.62, 0.160, 404, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
1079, 3ofuA, 0.7507, 3.53, 0.128, 396, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1080, 5y5fA, 0.7506, 3.44, 0.127, 399, 379, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
1081, 3oftA, 0.7505, 3.54, 0.128, 396, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1082, 3p6mA, 0.7504, 3.46, 0.151, 404, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
1083, 3ol5A, 0.7503, 3.50, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED WITH A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-C8-DANS
1084, 1wiyA, 0.7503, 2.46, 0.244, 358, 357, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1085, 5kdzA, 0.7502, 3.45, 0.141, 393, 383, THE CRYSTAL STRUCTURE OF THE T252A MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
1086, 1uedA, 0.7502, 3.26, 0.157, 391, 375, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
1087, 1lwlA, 0.7501, 3.56, 0.145, 404, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
1088, 3p6pA, 0.7500, 3.65, 0.150, 407, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C6-BIO
1089, 2zbyA, 0.7500, 3.14, 0.141, 400, 376, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT)
1090, 3oiaA, 0.7499, 3.50, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8GLUETG-BIO
1091, 5h1zA, 0.7498, 3.37, 0.127, 400, 379, CYP153D17 FROM SPHINGOMONAS SP. PAMC 26605
1092, 4oqrA, 0.7498, 3.06, 0.165, 386, 369, STRUCTURE OF A CYP105AS1 MUTANT IN COMPLEX WITH COMPACTIN
1093, 3rwlA, 0.7496, 3.41, 0.111, 404, 380, STRUCTURE OF P450PYR HYDROXYLASE
1094, 4fb2A, 0.7493, 3.43, 0.132, 392, 379, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1095, 4egoD, 0.7491, 3.47, 0.141, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1096, 3p6nA, 0.7491, 3.61, 0.150, 404, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
1097, 3p6wA, 0.7490, 3.42, 0.157, 400, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-ETG-BOC
1098, 3l62A, 0.7490, 3.40, 0.155, 400, 381, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT LOW [K+]
1099, 5l1pA, 0.7489, 3.37, 0.194, 397, 377, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE
1100, 3p3oA, 0.7489, 3.49, 0.181, 416, 381, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERMII) FROM STREPTOMYCES THIOLUTEUS
1101, 2zbxA, 0.7488, 3.28, 0.143, 399, 378, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (WILD TYPE) WITH IMIDAZOLE BOUND
1102, 4egpB, 0.7487, 3.40, 0.139, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
1103, 4do1D, 0.7487, 3.47, 0.138, 393, 383, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1104, 3p6vA, 0.7487, 3.42, 0.158, 398, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3ET-ADAC1-ETG-BOC
1105, 1uedB, 0.7487, 3.17, 0.150, 391, 373, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
1106, 4yzrA, 0.7486, 3.10, 0.167, 388, 372, BACILLUS SUBTILIS 168 BACILLAENE POLYKETIDE SYNTHASE (PKS) CYTOCHROME P450 PKSS
1107, 4egnD, 0.7486, 3.48, 0.138, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1108, 4l49A, 0.7484, 3.61, 0.142, 405, 386, STRUCTURE OF L358A MUTANT OF P450CAM BOUND TO CAMPHOR
1109, 5l1qA, 0.7483, 3.38, 0.194, 397, 377, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH DIHYDROPENTALENOLACTONE F
1110, 4egmD, 0.7483, 3.47, 0.144, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1111, 4dnzD, 0.7483, 3.47, 0.141, 393, 383, THE CRYSTAL STRUCTURES OF CYP199A4
1112, 3ofuB, 0.7483, 3.58, 0.125, 396, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1113, 4l4dA, 0.7482, 3.64, 0.145, 405, 386, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A
1114, 4l4eA, 0.7481, 3.65, 0.145, 405, 386, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G
1115, 2h7qA, 0.7481, 3.65, 0.145, 405, 386, CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
1116, 3nc3B, 0.7480, 3.08, 0.148, 385, 371, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1117, 3e5lA, 0.7480, 3.45, 0.178, 394, 377, CRYSTAL STRUCTURE OF CYP105P1 H72A MUTANT
1118, 1s1fA, 0.7479, 3.28, 0.154, 397, 377, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1119, 5l1sA, 0.7478, 3.38, 0.191, 397, 377, X-RAY STRUCTURE OF F232L MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1120, 4l4fA, 0.7478, 3.65, 0.145, 405, 386, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G/D182N
1121, 5l1uA, 0.7477, 3.36, 0.188, 397, 377, X-RAY STRUCTURE OF M81A MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1122, 5cp4A, 0.7477, 3.65, 0.145, 406, 386, CRYOGENIC STRUCTURE OF P450CAM
1123, 5l1vA, 0.7476, 3.38, 0.191, 397, 377, X-RAY STRUCTURE OF M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1124, 4l4aA, 0.7475, 3.65, 0.145, 405, 386, STRUCTURE OF L358A/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1125, 3p6rA, 0.7474, 3.43, 0.158, 398, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-ETG-BOC
1126, 1p7rA, 0.7474, 3.64, 0.147, 407, 387, CRYSTAL STRUCTURE OF REDUCED CO-EXPOSED COMPLEX OF CYTOCHROME P450CAM WITH (S)-(-)-NICOTINE
1127, 5wk7A, 0.7473, 3.75, 0.142, 405, 388, P450CAM MUTANT R186A
1128, 5l1rA, 0.7473, 3.38, 0.194, 397, 377, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PNTM
1129, 5l1oA, 0.7473, 3.39, 0.191, 397, 377, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1130, 4pwvA, 0.7472, 3.63, 0.169, 404, 384, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
1131, 3wvsA, 0.7472, 3.47, 0.177, 393, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450REVI
1132, 5wk9A, 0.7471, 3.75, 0.142, 405, 388, R186AP450CAM WITH CN AND CAMPHOR
1133, 3ofuD, 0.7471, 3.52, 0.128, 394, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1134, 1phcA, 0.7471, 3.65, 0.145, 405, 386, CRYSTAL STRUCTURE OF SUBSTRATE-FREE PSEUDOMONAS PUTIDA CYTOCHROME P450
1135, 1p2yA, 0.7471, 3.69, 0.145, 407, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM IN COMPLEX WITH (S)- (-)-NICOTINE
1136, 4l4bA, 0.7469, 3.69, 0.145, 405, 387, STRUCTURE OF L358A/K178G/D182N MUTANT OF P450CAM BOUND TO CAMPHOR
1137, 1pkfA, 0.7469, 3.41, 0.168, 403, 380, CRYSTAL STRUCTURE OF EPOTHILONE D-BOUND CYTOCHROME P450EPOK
1138, 1dz9A, 0.7469, 3.61, 0.145, 404, 385, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1139, 1dz8A, 0.7469, 3.69, 0.142, 404, 386, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1140, 1t86A, 0.7468, 3.65, 0.145, 406, 386, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
1141, 1gekA, 0.7468, 3.66, 0.145, 406, 386, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1142, 5l1tA, 0.7467, 3.40, 0.191, 397, 377, X-RAY STRUCTURE OF M77S MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1143, 3p6xA, 0.7467, 3.41, 0.158, 399, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C8-DANS
1144, 3nc7B, 0.7467, 3.12, 0.148, 384, 371, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1145, 1phbA, 0.7467, 3.65, 0.145, 405, 386, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
1146, 1o76A, 0.7467, 3.62, 0.145, 404, 385, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1147, 6gk6A, 0.7466, 3.46, 0.182, 403, 379, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYTOCHROME P450 CYP267B1 IN COMPLEX WITH MYRISTIC ACID 
1148, 6gk5A, 0.7466, 3.46, 0.182, 403, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP267B1 FROM SORANGIUM CELLULOSUM SO CE56 
1149, 6cppA, 0.7466, 3.69, 0.145, 405, 387, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1150, 5it1B, 0.7466, 3.63, 0.175, 395, 378, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
1151, 5it1C, 0.7465, 3.63, 0.175, 395, 378, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
1152, 3cp4A, 0.7465, 3.66, 0.145, 405, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1153, 1phaA, 0.7465, 3.65, 0.145, 405, 386, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
1154, 5it1D, 0.7464, 3.63, 0.175, 395, 378, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
1155, 5it1A, 0.7464, 3.63, 0.175, 395, 378, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
1156, 3ejdD, 0.7464, 3.10, 0.168, 385, 370, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1157, 1phfA, 0.7464, 3.66, 0.145, 405, 386, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1158, 4apyA, 0.7462, 3.55, 0.167, 414, 383, ETHYLENE GLYCOL-BOUND FORM OF P450 CYP125A3 FROM MYCOBACTERIUM SMEGMATIS
1159, 4cppA, 0.7461, 3.70, 0.145, 405, 387, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1160, 3ejbH, 0.7461, 3.17, 0.169, 387, 372, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1161, 1akdA, 0.7461, 3.66, 0.142, 405, 386, CYTOCHROME P450CAM FROM PSEUDOMONAS PUTIDA COMPLEXED WITH 1S-CAMPHOR
1162, 4ubsA, 0.7460, 3.29, 0.168, 393, 376, THE CRYSTAL STRUCTURE OF CYTOCHROME P450 105D7 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH DICLOFENAC
1163, 3l63A, 0.7460, 3.67, 0.145, 405, 386, CRYSTAL STRUCTURE OF CAMPHOR-BOUND P450CAM AT LOW [K+]
1164, 1t87B, 0.7460, 3.69, 0.145, 405, 386, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
1165, 1iwkA, 0.7460, 3.71, 0.145, 405, 387, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(112K) CYTOCHROME P450CAM
1166, 2ferA, 0.7459, 3.72, 0.142, 405, 387, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1167, 1t86B, 0.7459, 3.65, 0.142, 406, 386, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
1168, 6f8aB, 0.7458, 3.44, 0.172, 394, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1169, 5l1wA, 0.7458, 3.40, 0.186, 396, 377, X-RAY STRUCTURE OF 2-MERCAPTOETHANOL MODIFIED M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1170, 4kkyX, 0.7458, 3.60, 0.142, 411, 386, CRYSTAL STRUCTURE OF N-(1-PYRENE)ACETAMIDE LABELED P450CAM IN SUBSTRATE BOUND FORM.
1171, 2z3tA, 0.7458, 3.20, 0.172, 385, 372, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1172, 1dz6A, 0.7458, 3.69, 0.142, 404, 386, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
1173, 6cp4A, 0.7457, 3.69, 0.145, 405, 386, P450CAM D251N MUTANT
1174, 2z97A, 0.7457, 3.64, 0.148, 405, 386, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 7- METHYL-7-DEPROPIONATED HEMIN
1175, 2z3tC, 0.7457, 3.16, 0.178, 383, 371, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1176, 6f8cA, 0.7456, 3.43, 0.172, 394, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1177, 1pheA, 0.7456, 3.69, 0.145, 405, 386, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1178, 1gemA, 0.7456, 3.67, 0.145, 405, 386, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1179, 1cp4A, 0.7456, 3.70, 0.145, 405, 387, FORMATION CRYSTAL STRUCTURE AND REARRANGEMENT OF A CYTOCHROME P450-CAM IRON-PHENYL COMPLEX
1180, 3ejeD, 0.7455, 3.13, 0.168, 385, 370, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1181, 2bvjB, 0.7455, 3.62, 0.174, 391, 379, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
1182, 1phdA, 0.7455, 3.67, 0.145, 405, 386, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1183, 8cppA, 0.7454, 3.71, 0.145, 405, 387, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1184, 4fb2C, 0.7454, 3.43, 0.130, 390, 377, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1185, 3b99B, 0.7454, 3.53, 0.164, 415, 385, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1186, 2whwA, 0.7454, 3.56, 0.168, 396, 382, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1187, 2a1oB, 0.7454, 3.71, 0.142, 405, 386, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
1188, 1uyuA, 0.7454, 3.73, 0.142, 404, 387, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
1189, 1phgA, 0.7454, 3.68, 0.145, 405, 386, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1190, 1dz8B, 0.7454, 3.73, 0.142, 405, 387, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1191, 1o76B, 0.7453, 3.70, 0.145, 405, 386, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1192, 1nooA, 0.7453, 3.69, 0.145, 405, 386, CYTOCHROME P450-CAM COMPLEXED WITH 5-EXO-HYDROXYCAMPHOR
1193, 5livC, 0.7452, 3.44, 0.159, 395, 378, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1194, 5dqnA, 0.7452, 3.53, 0.160, 410, 382, POLYETHYLENE 600-BOUND FORM OF P450 CYP125A3 MUTANT FROM MYOBACTERIUM SMEGMATIS - W83Y
1195, 3cppA, 0.7452, 3.71, 0.145, 405, 387, CRYSTAL STRUCTURE OF THE CARBON MONOXY-SUBSTRATE-CYTOCHROME P450-CAM TERNARY COMPLEX
1196, 3oftB, 0.7451, 3.53, 0.129, 393, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1197, 2qbmA, 0.7451, 3.70, 0.145, 405, 386, CRYSTAL STRUCTURE OF THE P450CAM G248T MUTANT IN THE CYANIDE BOUND STATE
1198, 2cppA, 0.7451, 3.72, 0.145, 405, 387, HIGH-RESOLUTION CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM
1199, 1t88A, 0.7451, 3.67, 0.142, 407, 386, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
1200, 1t87A, 0.7451, 3.73, 0.145, 407, 387, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
1201, 1dz9B, 0.7451, 3.74, 0.142, 405, 387, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1202, 1dz6B, 0.7451, 3.70, 0.142, 405, 386, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
1203, 4cp4A, 0.7450, 3.69, 0.145, 405, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1204, 1dz4A, 0.7450, 3.71, 0.142, 404, 386, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
1205, 5cppA, 0.7449, 3.69, 0.145, 405, 386, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P-450(CAM)
1206, 4fb2B, 0.7449, 3.52, 0.132, 392, 379, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1207, 2h7sA, 0.7449, 3.73, 0.145, 405, 387, L244A MUTANT OF CYTOCHROME P450CAM
1208, 2frzA, 0.7449, 3.71, 0.145, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
1209, 2a1mB, 0.7449, 3.67, 0.148, 405, 386, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
1210, 1iwiA, 0.7449, 3.72, 0.145, 405, 387, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM
1211, 7cppA, 0.7448, 3.71, 0.145, 405, 387, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P450(CAM)
1212, 6f88A, 0.7448, 3.45, 0.172, 394, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
1213, 3wrmF, 0.7448, 3.67, 0.148, 405, 386, CRYSTAL STRUCTURE OF P450CAM
1214, 3wrlA, 0.7448, 3.73, 0.145, 405, 387, CRYSTAL STRUCTURE OF P450CAM
1215, 2cp4A, 0.7448, 3.72, 0.142, 405, 387, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1216, 2a1mA, 0.7448, 3.67, 0.148, 405, 386, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
1217, 1uyuB, 0.7448, 3.66, 0.145, 405, 386, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
1218, 4c9pA, 0.7447, 3.61, 0.148, 408, 386, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
1219, 2feuB, 0.7447, 3.71, 0.145, 405, 386, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1220, 1j51A, 0.7447, 3.66, 0.148, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1221, 1iwjA, 0.7447, 3.72, 0.147, 405, 387, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(109K) CYTOCHROME P450CAM
1222, 4l4gA, 0.7446, 3.78, 0.144, 405, 388, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358P/K178G
1223, 4c9nA, 0.7446, 3.61, 0.150, 408, 386, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
1224, 3wrhA, 0.7446, 3.74, 0.145, 405, 387, CRYSTAL STRUCTURE OF P450CAM
1225, 4ek1B, 0.7445, 3.73, 0.145, 404, 387, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
1226, 3wrjE, 0.7445, 3.67, 0.148, 405, 386, CRYSTAL STRUCTURE OF P450CAM
1227, 3ejbD, 0.7445, 3.18, 0.167, 386, 371, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1228, 2a1oA, 0.7445, 3.71, 0.145, 405, 386, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
1229, 4ek1A, 0.7444, 3.68, 0.145, 403, 386, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
1230, 3wrmA, 0.7444, 3.61, 0.143, 405, 385, CRYSTAL STRUCTURE OF P450CAM
1231, 1dz4B, 0.7444, 3.67, 0.140, 405, 386, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
1232, 4c9oA, 0.7443, 3.62, 0.148, 408, 386, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
1233, 2qblA, 0.7443, 3.71, 0.145, 405, 386, CRYSTAL STRUCTURE OF FERRIC G248T CYTOCHROME P450CAM
1234, 2m56A, 0.7443, 3.69, 0.140, 404, 386, THE STRUCTURE OF THE COMPLEX OF CYTOCHROME P450CAM AND ITS ELECTRON DONOR PUTIDAREDOXIN DETERMINED BY PARAMAGNETIC NMR SPECTROSCOPY
1235, 2gqxA, 0.7443, 3.74, 0.145, 405, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
1236, 2a1nB, 0.7443, 3.69, 0.148, 405, 386, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
1237, 1t88B, 0.7443, 3.58, 0.143, 405, 384, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
1238, 1t85A, 0.7443, 3.75, 0.142, 406, 387, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM MUTANT (L358P/C334A)
1239, 1mpwA, 0.7443, 3.61, 0.143, 405, 385, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
1240, 1c8jA, 0.7443, 3.71, 0.145, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
1241, 3wrjA, 0.7442, 3.61, 0.143, 405, 385, CRYSTAL STRUCTURE OF P450CAM
1242, 3wrhE, 0.7442, 3.68, 0.142, 405, 386, CRYSTAL STRUCTURE OF P450CAM
1243, 3tzoB, 0.7442, 3.51, 0.143, 402, 378, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1244, 3fwgA, 0.7442, 3.68, 0.145, 404, 386, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
1245, 1j51C, 0.7442, 3.74, 0.145, 405, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1246, 1j51B, 0.7442, 3.65, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1247, 4umzA, 0.7441, 3.64, 0.167, 396, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
1248, 4c9lB, 0.7441, 3.67, 0.145, 407, 387, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
1249, 4c9lA, 0.7441, 3.69, 0.142, 408, 388, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
1250, 4c9kB, 0.7441, 3.69, 0.144, 407, 388, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
1251, 2gr6B, 0.7441, 3.64, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
1252, 3wrlE, 0.7440, 3.61, 0.148, 405, 385, CRYSTAL STRUCTURE OF P450CAM
1253, 2gr6A, 0.7440, 3.74, 0.145, 405, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
1254, 2a1nA, 0.7440, 3.75, 0.147, 407, 387, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
1255, 1mpwB, 0.7440, 3.65, 0.148, 405, 385, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
1256, 4c9mB, 0.7439, 3.72, 0.150, 407, 387, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
1257, 4c9mA, 0.7439, 3.62, 0.148, 408, 386, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
1258, 4c9kA, 0.7439, 3.62, 0.148, 408, 386, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
1259, 3lxhA, 0.7439, 3.62, 0.150, 408, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
1260, 2h7sC, 0.7439, 3.71, 0.145, 405, 386, L244A MUTANT OF CYTOCHROME P450CAM
1261, 1j51D, 0.7439, 3.65, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1262, 4l4cA, 0.7438, 3.76, 0.145, 405, 387, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1263, 4c9pB, 0.7438, 3.62, 0.145, 407, 386, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
1264, 4c9oB, 0.7437, 3.70, 0.144, 407, 388, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
1265, 4wq0A, 0.7436, 3.52, 0.175, 397, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH OLIGOMYCIN A
1266, 2wi9A, 0.7436, 3.59, 0.168, 396, 382, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1267, 5de9A, 0.7435, 3.52, 0.143, 402, 378, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1268, 3tywD, 0.7435, 3.50, 0.144, 399, 376, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1269, 1gebA, 0.7435, 3.67, 0.145, 405, 386, X-RAY CRYSTAL STRUCTURE AND CATALYTIC PROPERTIES OF THR252ILE MUTANT OF CYTOCHROME P450CAM
1270, 5cjeA, 0.7434, 3.47, 0.162, 390, 376, STRUCTURE OF CYP107L2
1271, 4fb2D, 0.7434, 3.51, 0.130, 391, 378, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1272, 4c9nB, 0.7434, 3.71, 0.144, 407, 388, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
1273, 4bf4M, 0.7434, 3.64, 0.165, 397, 382, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1274, 4bf4D, 0.7434, 3.68, 0.162, 397, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1275, 2zaxA, 0.7434, 3.62, 0.143, 405, 385, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
1276, 2gqxB, 0.7434, 3.66, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
1277, 1yrdA, 0.7434, 3.58, 0.143, 405, 384, X-RAY CRYSTAL STRUCTURE OF PERDEUTERATED CYTOCHROME P450CAM
1278, 2zwuA, 0.7433, 3.62, 0.143, 405, 385, CRYSTAL STRUCTURE OF CAMPHOR SOAKED FERRIC CYTOCHROME P450CAM
1279, 2zuiA, 0.7433, 3.62, 0.143, 405, 385, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297N)
1280, 1q5eA, 0.7433, 3.49, 0.168, 404, 380, SUBSTRATE-FREE CYTOCHROME P450EPOK
1281, 2zuhA, 0.7432, 3.62, 0.148, 405, 385, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297A)
1282, 2qboA, 0.7432, 3.76, 0.147, 405, 387, CRYSTAL STRUCTURE OF THE P450CAM G248V MUTANT IN THE CYANIDE BOUND STATE
1283, 2feuA, 0.7432, 3.74, 0.145, 404, 386, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1284, 5de9B, 0.7431, 3.51, 0.142, 402, 379, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1285, 4bf4N, 0.7431, 3.67, 0.167, 397, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1286, 3fwgB, 0.7431, 3.63, 0.138, 405, 385, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
1287, 2x5lA, 0.7431, 3.58, 0.147, 414, 381, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 ALTERNATIVE CRYSTAL FORM
1288, 5y1iA, 0.7430, 3.39, 0.137, 388, 372, THE CRYSTAL STRUCTURE OF GFSF
1289, 3lxiB, 0.7430, 3.63, 0.150, 407, 386, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
1290, 3lxiA, 0.7430, 3.63, 0.148, 408, 386, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
1291, 4bf4J, 0.7429, 3.66, 0.165, 397, 382, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1292, 2zwtA, 0.7429, 3.63, 0.143, 405, 385, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
1293, 2qbnA, 0.7429, 3.76, 0.145, 405, 387, CRYSTAL STRUCTURE OF FERRIC G248V CYTOCHROME P450CAM
1294, 3ejdB, 0.7428, 3.03, 0.177, 382, 367, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1295, 2zawA, 0.7428, 3.58, 0.143, 405, 384, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 6- METHYL-6-DEPROPIONATED HEMIN
1296, 2vz7A, 0.7428, 3.59, 0.168, 396, 382, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1297, 1yrcA, 0.7428, 3.59, 0.143, 405, 384, X-RAY CRYSTAL STRUCTURE OF HYDROGENATED CYTOCHROME P450CAM
1298, 3tzoA, 0.7427, 3.54, 0.143, 402, 378, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1299, 2zujA, 0.7427, 3.63, 0.143, 405, 385, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT(D297L)
1300, 2fe6A, 0.7427, 3.73, 0.145, 405, 386, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1301, 4bf4O, 0.7426, 3.63, 0.165, 397, 382, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1302, 3fwiA, 0.7426, 3.74, 0.140, 405, 386, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND TETRAGONAL CRYSTAL FORM
1303, 1q5dA, 0.7426, 3.42, 0.175, 401, 378, EPOTHILONE B-BOUND CYTOCHROME P450EPOK
1304, 5gweB, 0.7425, 3.30, 0.169, 396, 373, CYTOCHROME P450 CREJ
1305, 3oftC, 0.7425, 3.49, 0.127, 390, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1306, 5xntA, 0.7424, 3.63, 0.190, 392, 378, STRUCTURE OF CYP106A2 FROM BACILLUS SP. PAMC 23377
1307, 3iw0A, 0.7422, 3.54, 0.153, 407, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 C2221 CRYSTAL FORM
1308, 3nc5A, 0.7421, 3.06, 0.150, 384, 367, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1309, 1c8jB, 0.7421, 3.65, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
1310, 4bf4B, 0.7420, 3.63, 0.165, 397, 382, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1311, 4g3rA, 0.7419, 3.65, 0.143, 407, 385, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
1312, 6f85B, 0.7418, 3.43, 0.171, 392, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
1313, 3tywC, 0.7418, 3.51, 0.141, 398, 375, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1314, 3ejeH, 0.7418, 3.13, 0.171, 383, 368, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1315, 2frzB, 0.7417, 3.71, 0.145, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
1316, 4g3rB, 0.7416, 3.72, 0.148, 405, 386, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
1317, 4umzB, 0.7415, 3.65, 0.165, 395, 382, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
1318, 4bf4L, 0.7414, 3.59, 0.163, 397, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1319, 3fwjA, 0.7413, 3.65, 0.143, 405, 385, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND ORTHOROMBIC CRYSTAL FORM
1320, 2h7rA, 0.7413, 3.77, 0.145, 405, 386, L244A MUTANT OF CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
1321, 4l4cB, 0.7412, 3.66, 0.145, 405, 385, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1322, 4bf4E, 0.7411, 3.66, 0.165, 397, 382, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1323, 3lxhB, 0.7411, 3.63, 0.148, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
1324, 4b7dB, 0.7410, 3.58, 0.166, 393, 380, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
1325, 3ejdF, 0.7410, 3.02, 0.172, 381, 366, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1326, 4bf4H, 0.7409, 3.64, 0.165, 396, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1327, 3ofuE, 0.7409, 3.51, 0.130, 390, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1328, 3ejdH, 0.7409, 3.08, 0.172, 382, 367, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1329, 2xc3A, 0.7408, 3.54, 0.150, 409, 379, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP125 BOUND TO THE REVERSE TYPE I INHIBITOR
1330, 2xfhA, 0.7407, 3.53, 0.164, 394, 378, STRUCTURE OF CYTOCHROME P450 ERYK COCRYSTALLIZED WITH INHIBITOR CLOTRIMAZOLE.
1331, 2z3tD, 0.7406, 3.12, 0.171, 379, 368, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1332, 2wi9B, 0.7406, 3.58, 0.166, 394, 380, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1333, 2vzmA, 0.7406, 3.61, 0.168, 395, 381, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
1334, 5livA, 0.7405, 3.49, 0.168, 397, 376, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1335, 1se6B, 0.7405, 3.55, 0.146, 402, 377, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1336, 1gjmA, 0.7405, 3.75, 0.143, 405, 385, COVALENT ATTACHMENT OF AN ELECTROACTIVE SULPHYDRYL REAGENT IN THE ACTIVE SITE OF CYTOCHROME P450CAM
1337, 3zpiB, 0.7404, 3.67, 0.168, 396, 382, PIKC D50N MUTANT IN P21 SPACE GROUP
1338, 4bf4P, 0.7402, 3.61, 0.166, 396, 380, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1339, 4bf4F, 0.7402, 3.57, 0.163, 396, 380, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1340, 3ofuF, 0.7402, 3.57, 0.129, 390, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1341, 2whwB, 0.7402, 3.55, 0.166, 393, 379, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1342, 5ibeA, 0.7401, 3.59, 0.156, 394, 378, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25A
1343, 4ktkA, 0.7400, 3.52, 0.154, 394, 377, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-4-(4-HYDROXYPHENYL)-1H-PYRAZOL-5-YL)BENZENE-13-DIOL
1344, 4g1xA, 0.7400, 3.57, 0.151, 394, 378, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(1H-124-TRIAZOL-1-YL)QUINOLIN-6-AMINE
1345, 4bf4A, 0.7400, 3.62, 0.165, 396, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1346, 3g5fA, 0.7399, 3.58, 0.153, 394, 378, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
1347, 6f8cB, 0.7398, 3.59, 0.170, 394, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1348, 5o4kA, 0.7397, 3.58, 0.153, 394, 378, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6B.
1349, 3zk5A, 0.7397, 3.71, 0.162, 397, 383, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
1350, 3l61A, 0.7397, 3.44, 0.154, 396, 377, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT 200 MM [K+]
1351, 3fwfB, 0.7397, 3.82, 0.137, 405, 387, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
1352, 5op9A, 0.7396, 3.54, 0.151, 394, 377, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7E
1353, 5li8A, 0.7396, 3.37, 0.152, 390, 374, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH KETOCONAZOLE
1354, 5ibjA, 0.7396, 3.49, 0.157, 393, 376, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 6
1355, 5ex8A, 0.7396, 3.57, 0.136, 414, 375, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; ETHYLENE GLYCOL CRYO
1356, 4g47A, 0.7396, 3.51, 0.151, 394, 377, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-(1H-124- TRIAZOL-1-YL)PHENOL
1357, 4bf4G, 0.7396, 3.63, 0.165, 396, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1358, 3cxvA, 0.7396, 3.58, 0.151, 394, 378, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 A233G MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
1359, 5ibdA, 0.7395, 3.48, 0.154, 394, 376, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 24A
1360, 5cweA, 0.7395, 3.56, 0.159, 393, 378, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
1361, 4ktjA, 0.7395, 3.58, 0.151, 394, 378, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-1H-PYRAZOL-4-YL)PHENOL
1362, 4g44A, 0.7395, 3.51, 0.151, 394, 377, STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND MB286 3-((1H- 124-TRIAZOL-1-YL)METHYL)ANILINE
1363, 4g2gA, 0.7395, 3.58, 0.153, 394, 378, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(1H-123-TRIAZOLE-15-DIYL)DIPHENOL
1364, 3cxxA, 0.7395, 3.59, 0.151, 394, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 F338H FROM M. TUBERCULOSIS
1365, 2xn8A, 0.7395, 3.60, 0.153, 409, 380, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125
1366, 3e5kA, 0.7394, 3.28, 0.171, 382, 369, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE 4-PHENYLIMIDAZOLE COMPLEX
1367, 3cxzA, 0.7394, 3.59, 0.151, 394, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 R386L MUTANT FROM M. TUBERCULOSIS
1368, 4g48A, 0.7393, 3.49, 0.152, 394, 376, STRUCTURE OF CYP121 IN COMPLEX WITH 4-(4-PHENOXY-1H-PYRAZOL-3-YL) BENZENE-13-DIOL
1369, 5ibhA, 0.7392, 3.52, 0.154, 393, 377, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26H
1370, 5edtA, 0.7392, 3.56, 0.151, 394, 378, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH LIG9
1371, 4g46A, 0.7392, 3.52, 0.154, 394, 377, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-OXO-4567- TETRAHYDROBENZOFURAN-3-CARBOXYLATE
1372, 3zk5B, 0.7392, 3.62, 0.166, 394, 380, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
1373, 1n40A, 0.7392, 3.58, 0.151, 394, 378, ATOMIC STRUCTURE OF CYP121 A MYCOBACTERIAL P450
1374, 4ktlA, 0.7391, 3.53, 0.154, 394, 377, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-((4-HYDROXYPHENYL)AMINO)-1H-PYRAZOLE-45-DIYL)DIPHENOL
1375, 3cxyA, 0.7391, 3.47, 0.149, 393, 376, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 P346L MUTANT FROM M. TUBERCULOSIS
1376, 3ejbB, 0.7390, 3.04, 0.173, 380, 365, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1377, 5ex9A, 0.7389, 3.64, 0.136, 414, 376, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; GLYCEROL CRYO
1378, 4b7sA, 0.7389, 3.62, 0.163, 397, 381, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
1379, 3zpiA, 0.7389, 3.72, 0.168, 396, 382, PIKC D50N MUTANT IN P21 SPACE GROUP
1380, 2vzmB, 0.7389, 3.60, 0.166, 394, 380, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
1381, 2vz7B, 0.7389, 3.58, 0.166, 393, 379, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1382, 6f8aA, 0.7388, 3.57, 0.165, 394, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1383, 4bf4I, 0.7388, 3.73, 0.168, 396, 382, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1384, 3cy1A, 0.7388, 3.59, 0.151, 394, 378, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 S279A MUTANT FROM M. TUBERCULOSIS
1385, 4g45A, 0.7387, 3.54, 0.154, 394, 377, STRUCTURE OF CYTOCHROME CYP121 IN COMPLEX WITH 2-METHYLQUINOLIN-6- AMINE
1386, 5wp2A, 0.7386, 3.54, 0.154, 394, 377, 1.44 ANGSTROM CRYSTAL STRUCTURE OF CYP121 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH SUBSTRATE AND CN 
1387, 4bf4K, 0.7386, 3.64, 0.163, 397, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1388, 2y5nB, 0.7386, 3.47, 0.176, 400, 374, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
1389, 4ipsA, 0.7385, 3.54, 0.154, 394, 377, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1390, 4ictA, 0.7385, 3.53, 0.154, 394, 377, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1391, 3fwfA, 0.7385, 3.71, 0.140, 404, 385, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
1392, 3ejeF, 0.7385, 3.06, 0.170, 380, 365, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1393, 5o4lA, 0.7384, 3.58, 0.154, 393, 377, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6A.
1394, 5l91A, 0.7384, 3.65, 0.204, 391, 373, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
1395, 5ik1A, 0.7384, 3.43, 0.160, 394, 375, OPEN STATE OF P450CAM AFTER SOAKING IN CAMPHOR
1396, 5ibiA, 0.7384, 3.49, 0.152, 393, 376, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26A
1397, 5ex6A, 0.7384, 3.15, 0.136, 386, 367, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1398, 4iq7A, 0.7384, 3.54, 0.151, 394, 377, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1399, 4bf4C, 0.7384, 3.62, 0.163, 396, 380, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1400, 3cy0A, 0.7384, 3.54, 0.151, 394, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 S237A MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
1401, 3a4hA, 0.7384, 3.64, 0.159, 400, 377, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (ORTHORHOMBIC CRYSTAL FORM)
1402, 3iw2A, 0.7383, 3.35, 0.147, 398, 373, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ECONAZOLE
1403, 2dkkA, 0.7383, 3.74, 0.134, 399, 381, STRUCTURE/FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1404, 4ipwA, 0.7382, 3.50, 0.154, 394, 376, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1405, 3wecA, 0.7382, 3.57, 0.138, 401, 378, STRUCTURE OF P450 RAUA (CYP1050A1) COMPLEXED WITH A BIOSYNTHETIC INTERMEDIATE OF AURACHIN RE
1406, 5cweB, 0.7380, 3.54, 0.159, 393, 377, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
1407, 4iq9A, 0.7379, 3.53, 0.154, 394, 377, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1408, 5ibfA, 0.7378, 3.48, 0.149, 393, 376, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 19A
1409, 3iw1A, 0.7378, 3.37, 0.147, 398, 373, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ANDROSTENEDIONE
1410, 3e5jA, 0.7378, 3.48, 0.179, 390, 374, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE LIGAND-FREE FORM
1411, 2c6hB, 0.7378, 3.63, 0.166, 394, 380, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1412, 5mnsE, 0.7377, 3.46, 0.170, 395, 377, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1413, 3ivyA, 0.7377, 3.43, 0.147, 399, 374, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 P212121 CRYSTAL FORM
1414, 3g5hA, 0.7377, 3.53, 0.151, 394, 377, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
1415, 3mgxB, 0.7376, 3.33, 0.159, 391, 371, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
1416, 2c6hA, 0.7376, 3.58, 0.166, 393, 379, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1417, 2jjpA, 0.7375, 3.60, 0.166, 397, 379, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH INHIBITOR KETOCONAZOLE (KC)
1418, 5ex6C, 0.7374, 3.17, 0.136, 388, 367, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1419, 4ktfA, 0.7374, 3.52, 0.152, 392, 376, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-AMINO-1H-PYRAZOLE-45-DIYL)DIPHENOL
1420, 3tywA, 0.7374, 3.57, 0.142, 397, 374, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1421, 6f85A, 0.7373, 3.56, 0.171, 392, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
1422, 5opaA, 0.7373, 3.51, 0.154, 393, 376, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7B
1423, 3tywB, 0.7372, 3.58, 0.142, 397, 374, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1424, 2y5zC, 0.7372, 3.52, 0.176, 394, 375, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1425, 2c7xA, 0.7372, 3.79, 0.167, 396, 383, CRYSTAL STRUCTURE OF NARBOMYCIN-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1426, 2nz5A, 0.7371, 3.72, 0.137, 399, 380, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1427, 4jwsB, 0.7368, 3.54, 0.168, 395, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
1428, 4aw3B, 0.7367, 3.38, 0.170, 393, 371, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
1429, 2ycaA, 0.7367, 3.38, 0.170, 393, 371, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN P21212 SPACE GROUP
1430, 2y5zB, 0.7367, 3.54, 0.176, 394, 375, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1431, 2lqdA, 0.7366, 3.69, 0.156, 405, 384, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1432, 6f88B, 0.7365, 3.63, 0.165, 393, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
1433, 4b7dA, 0.7364, 3.60, 0.166, 393, 379, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
1434, 3r9bC, 0.7364, 3.46, 0.177, 391, 373, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1435, 3ejbF, 0.7364, 3.20, 0.167, 378, 366, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1436, 2ij5C, 0.7364, 3.47, 0.152, 394, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1437, 4b7sB, 0.7363, 3.57, 0.164, 393, 378, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
1438, 3r9bB, 0.7363, 3.46, 0.177, 391, 373, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1439, 3r9bA, 0.7363, 3.46, 0.177, 391, 373, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1440, 4ggvA, 0.7361, 3.41, 0.156, 396, 371, CRYSTAL STRUCTURE OF HMTT INVOLVED IN HIMASTATIN BIOSYNTHESIS
1441, 2y5nA, 0.7361, 3.57, 0.179, 394, 375, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
1442, 2ij7E, 0.7361, 3.53, 0.157, 391, 376, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1443, 2ij5B, 0.7361, 3.42, 0.152, 390, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1444, 2jjoA, 0.7360, 3.59, 0.162, 393, 376, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH ITS NATURAL SUBSTRATE ERD
1445, 4xe3B, 0.7358, 3.58, 0.170, 394, 376, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
1446, 2ij7B, 0.7356, 3.46, 0.155, 391, 374, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1447, 1lgfA, 0.7356, 3.26, 0.141, 388, 368, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1448, 2ca0A, 0.7355, 3.57, 0.164, 393, 378, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
1449, 4tx3A, 0.7353, 3.06, 0.135, 373, 363, COMPLEX OF THE X-DOMAIN AND OXYB FROM TEICOPLANIN BIOSYNTHESIS
1450, 3nc7A, 0.7353, 3.07, 0.151, 379, 364, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1451, 2ygxD, 0.7353, 3.55, 0.176, 393, 375, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1452, 5l91B, 0.7352, 3.57, 0.208, 389, 371, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
1453, 4wpzA, 0.7352, 3.38, 0.178, 386, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS
1454, 2jjnA, 0.7352, 3.66, 0.164, 395, 379, STRUCTURE OF CLOSED CYTOCHROME P450 ERYK
1455, 3zsnC, 0.7351, 3.53, 0.171, 393, 374, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1456, 3zsnB, 0.7351, 3.53, 0.176, 393, 374, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1457, 3mgxA, 0.7351, 3.32, 0.159, 387, 370, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
1458, 2ygxB, 0.7351, 3.56, 0.176, 393, 375, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1459, 1n4gA, 0.7351, 3.43, 0.153, 392, 373, STRUCTURE OF CYP121 A MYCOBACTERIAL P450 IN COMPLEX WITH IODOPYRAZOLE
1460, 3zsnA, 0.7350, 3.53, 0.174, 393, 374, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1461, 4yt3B, 0.7349, 3.35, 0.182, 388, 369, CYP106A2
1462, 3abbA, 0.7349, 3.24, 0.166, 383, 367, CRYSTAL STRUCTURE OF CYP105D6
1463, 5mnsA, 0.7348, 3.49, 0.170, 395, 377, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1464, 5hdiA, 0.7348, 3.37, 0.174, 397, 373, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
1465, 5gnmC, 0.7348, 3.71, 0.159, 401, 377, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1466, 3ejeB, 0.7348, 3.05, 0.168, 378, 363, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1467, 2y5zA, 0.7347, 3.54, 0.176, 393, 374, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1468, 5vwsA, 0.7346, 3.23, 0.161, 376, 366, LIGAND FREE STRUCTURE OF CYTOCHROME P450 TBTJ1
1469, 5l90A, 0.7346, 3.58, 0.205, 385, 370, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
1470, 4jwsA, 0.7346, 3.42, 0.153, 392, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
1471, 2z3tB, 0.7346, 3.07, 0.173, 376, 364, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1472, 5l90B, 0.7345, 3.58, 0.211, 385, 370, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
1473, 4z5pA, 0.7345, 3.47, 0.175, 388, 371, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
1474, 2y46C, 0.7345, 3.55, 0.179, 393, 374, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1475, 5mnsB, 0.7344, 3.50, 0.170, 395, 377, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1476, 5gnmD, 0.7344, 3.66, 0.162, 401, 376, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1477, 2y46B, 0.7344, 3.54, 0.176, 393, 374, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1478, 2ij5A, 0.7343, 3.50, 0.157, 392, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1479, 2y46A, 0.7342, 3.55, 0.179, 393, 374, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1480, 5mnvC, 0.7341, 3.60, 0.164, 396, 379, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1481, 5ibgA, 0.7341, 3.39, 0.151, 390, 372, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25B
1482, 2ygxA, 0.7341, 3.54, 0.179, 393, 374, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1483, 4xe3A, 0.7340, 3.62, 0.165, 394, 376, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
1484, 3nc3A, 0.7340, 3.05, 0.152, 380, 363, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1485, 2ygxC, 0.7339, 3.55, 0.176, 393, 374, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1486, 2nz5B, 0.7339, 3.81, 0.140, 399, 379, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1487, 2ij7D, 0.7339, 3.49, 0.158, 391, 374, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1488, 5ex6B, 0.7337, 2.96, 0.139, 371, 361, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1489, 4z5pB, 0.7337, 3.49, 0.170, 388, 371, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
1490, 5ofqD, 0.7336, 3.62, 0.177, 387, 373, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1491, 5mnsD, 0.7336, 3.57, 0.164, 395, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1492, 3a51D, 0.7336, 3.76, 0.169, 402, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1493, 2ij5D, 0.7336, 3.51, 0.158, 391, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1494, 5mnsC, 0.7335, 3.59, 0.167, 395, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1495, 2xbkA, 0.7335, 3.25, 0.150, 391, 367, X-RAY STRUCTURE OF THE SUBSTRATE-BOUND CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
1496, 2nzaA, 0.7335, 3.69, 0.140, 397, 378, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1497, 2bvjA, 0.7334, 3.67, 0.164, 394, 379, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
1498, 5mnvB, 0.7332, 3.49, 0.173, 394, 376, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1499, 2y98A, 0.7331, 3.60, 0.179, 393, 375, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN P21212 SPACE GROUP
1500, 2ij7F, 0.7329, 3.44, 0.155, 391, 373, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1501, 2ij7A, 0.7329, 3.37, 0.156, 391, 372, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1502, 2ij7C, 0.7326, 3.44, 0.155, 391, 373, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1503, 2wioA, 0.7325, 3.77, 0.162, 393, 377, STRUCTURE OF THE  HISTIDINE TAGGED OPEN CYTOCHROME P450 ERYK FROM S. ERYTHRAEA
1504, 2cd8B, 0.7323, 3.69, 0.166, 392, 379, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1505, 2cd8A, 0.7322, 3.68, 0.167, 391, 378, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1506, 4yt3A, 0.7320, 3.35, 0.179, 388, 368, CYP106A2
1507, 5livB, 0.7319, 3.58, 0.168, 389, 376, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1508, 5l92A, 0.7319, 3.48, 0.204, 386, 372, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
1509, 5ofqA, 0.7318, 3.77, 0.173, 386, 375, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1510, 3a51A, 0.7318, 3.79, 0.175, 402, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1511, 3r9cA, 0.7316, 3.55, 0.187, 400, 374, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 WITH ECONAZOLE BOUND
1512, 3wrkD, 0.7315, 3.39, 0.159, 392, 371, CRYSTAL STRUCTURE OF P450CAM
1513, 2l8mA, 0.7315, 3.75, 0.141, 405, 384, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1514, 5d40A, 0.7312, 3.72, 0.145, 403, 380, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1515, 4aw3A, 0.7312, 3.56, 0.179, 393, 374, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
1516, 3a50A, 0.7312, 3.80, 0.175, 402, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1517, 3a4zA, 0.7312, 3.81, 0.175, 402, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1518, 5d3uA, 0.7311, 3.73, 0.145, 403, 380, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1519, 4fxbA, 0.7311, 3.37, 0.144, 390, 369, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
1520, 2ca0B, 0.7311, 3.65, 0.159, 393, 378, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
1521, 5gnmB, 0.7310, 3.68, 0.160, 399, 375, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1522, 3a4zE, 0.7308, 3.67, 0.171, 401, 375, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1523, 5livD, 0.7307, 3.60, 0.160, 389, 375, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1524, 3zkpA, 0.7307, 3.60, 0.166, 390, 374, STRUCTURE OF A MUTANT OF P450 ERYK IN COMPLEX WITH ERYTHROMYCIN B.
1525, 3a51E, 0.7307, 3.66, 0.168, 401, 375, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1526, 3vrmA, 0.7306, 3.43, 0.175, 402, 371, STRUCTURE OF CYTOCHROME P450 VDH MUTANT T107A WITH BOUND VITAMIN D3
1527, 3a4zD, 0.7306, 3.73, 0.173, 401, 376, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1528, 2uuqA, 0.7306, 3.48, 0.137, 394, 373, CRYSTAL STRUCTURE OF CYP130 FROM MYCOBACTERIUM TUBERCULOSIS IN THE LIGAND-FREE FORM
1529, 3nc6A, 0.7304, 2.94, 0.153, 374, 360, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
1530, 3nc5B, 0.7303, 3.00, 0.147, 373, 360, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1531, 3a51B, 0.7302, 3.58, 0.174, 402, 374, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1532, 5ofqC, 0.7301, 3.74, 0.174, 386, 374, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1533, 3a50D, 0.7301, 3.73, 0.176, 401, 376, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1534, 6fshD, 0.7298, 3.27, 0.131, 382, 366, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1535, 5mnvA, 0.7298, 3.68, 0.162, 397, 376, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1536, 3a4zB, 0.7297, 3.59, 0.171, 402, 374, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1537, 3a51C, 0.7296, 3.73, 0.170, 401, 376, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1538, 5d40B, 0.7295, 3.75, 0.145, 403, 380, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1539, 3a50E, 0.7295, 3.69, 0.165, 401, 375, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1540, 3a50B, 0.7295, 3.60, 0.174, 402, 374, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1541, 3wrkA, 0.7294, 3.45, 0.162, 391, 371, CRYSTAL STRUCTURE OF P450CAM
1542, 5d3uB, 0.7293, 3.78, 0.150, 403, 381, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1543, 5l94A, 0.7292, 3.50, 0.199, 385, 371, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
1544, 3a4gA, 0.7291, 3.62, 0.169, 395, 373, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (TRIGONAL CRYSTAL FORM)
1545, 2whfA, 0.7291, 3.50, 0.137, 394, 373, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1546, 1lg9A, 0.7291, 3.10, 0.136, 377, 361, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1547, 5mnvH, 0.7290, 3.71, 0.164, 395, 377, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1548, 3a4zC, 0.7289, 3.69, 0.171, 401, 375, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1549, 5hiwA, 0.7288, 3.52, 0.139, 391, 373, SORANGIUM CELLULOSUM SO CE56 CYTOCHROME P450 260B1
1550, 5gnmA, 0.7288, 3.67, 0.166, 399, 374, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1551, 3a50C, 0.7288, 3.75, 0.170, 401, 376, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1552, 2nzaB, 0.7286, 3.78, 0.138, 388, 376, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1553, 2ij5E, 0.7286, 3.53, 0.153, 387, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1554, 5yswA, 0.7283, 2.99, 0.137, 374, 358, CRYSTAL STRUCTURE ANALYSIS OF RIF16 IN COMPLEX WITH R-L 
1555, 5l92B, 0.7283, 3.18, 0.212, 370, 359, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
1556, 4tpoA, 0.7283, 3.74, 0.150, 398, 379, HIGH-RESOLUTION STRUCTURE OF TXTE WITH BOUND TRYPTOPHAN SUBSTRATE
1557, 5ikiA, 0.7282, 3.39, 0.185, 383, 367, CYP106A2 WITH SUBSTRATE ABIETIC ACID
1558, 4oqsA, 0.7281, 3.64, 0.154, 384, 369, CRYSTAL STRUCTURE OF CYP105AS1
1559, 5kyoB, 0.7280, 3.56, 0.149, 393, 375, CRYSTAL STRUCTURE OF CYP101J2
1560, 5mnvD, 0.7279, 3.60, 0.164, 394, 373, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1561, 5mnsF, 0.7278, 3.63, 0.165, 393, 376, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1562, 1lfkA, 0.7276, 3.21, 0.138, 375, 363, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1563, 5gnlA, 0.7275, 3.73, 0.168, 395, 375, CYTOCHROME P450 VDH (CYP107BR1) F106V MUTANT
1564, 2wgyA, 0.7273, 3.50, 0.140, 394, 372, CRYSTAL STRUCTURE OF THE G243A MUTANT OF CYP130 FROM M. TUBERCULOSIS
1565, 6fshA, 0.7272, 3.16, 0.129, 378, 363, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1566, 5lieB, 0.7270, 3.61, 0.155, 397, 373, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
1567, 2ij5F, 0.7269, 3.40, 0.154, 384, 369, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1568, 6fshB, 0.7263, 3.29, 0.132, 380, 365, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1569, 5ofqB, 0.7263, 3.75, 0.177, 386, 373, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1570, 5kyoA, 0.7261, 3.56, 0.150, 394, 374, CRYSTAL STRUCTURE OF CYP101J2
1571, 5mnvF, 0.7259, 3.73, 0.162, 395, 376, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1572, 3o1aA, 0.7257, 3.28, 0.156, 383, 360, STRUCTURE OF OXYE (CYP165D3) A CYTOCHROME P450 INVOLVED IN TEICOPLANIN BIOSYNTHESIS
1573, 2wh8A, 0.7255, 3.54, 0.137, 392, 371, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1574, 4l36A, 0.7252, 3.73, 0.149, 396, 377, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1575, 6fshC, 0.7251, 3.28, 0.132, 380, 364, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1576, 5hdiB, 0.7251, 3.40, 0.168, 393, 369, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
1577, 5kyoE, 0.7250, 3.65, 0.141, 390, 376, CRYSTAL STRUCTURE OF CYP101J2
1578, 5uhuA, 0.7247, 3.67, 0.147, 393, 373, SOLUTION CONFORMATION OF CYTOCHROME P450 MYCG WITH MYCINAMICIN IV BOUND
1579, 2wh8D, 0.7246, 3.53, 0.133, 389, 369, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1580, 5hh3A, 0.7241, 3.59, 0.128, 381, 367, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1581, 2wh8B, 0.7240, 3.48, 0.130, 392, 368, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1582, 5hh3C, 0.7236, 3.62, 0.122, 393, 370, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1583, 5mnvE, 0.7229, 3.50, 0.160, 390, 369, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1584, 2wh8C, 0.7229, 3.50, 0.136, 388, 368, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1585, 5kyoC, 0.7227, 3.55, 0.142, 390, 372, CRYSTAL STRUCTURE OF CYP101J2
1586, 4tpnA, 0.7220, 3.73, 0.149, 386, 375, HIGH-RESOLUTION STRUCTURE OF TXTE IN THE ABSENCE OF SUBSTRATE
1587, 3oo3A, 0.7207, 3.09, 0.154, 371, 356, CRYSTAL STRUCTURE OF THE ORF6* (CYP165D3) MONOOXYGENASE INVOLVED IN TEICOPLANIN BIOSYNTHESIS
1588, 4fxbB, 0.7204, 3.19, 0.153, 370, 359, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
1589, 2uvnA, 0.7204, 3.85, 0.131, 399, 374, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
1590, 1se6A, 0.7181, 3.29, 0.160, 384, 362, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1591, 5l94B, 0.7179, 3.01, 0.204, 360, 353, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
1592, 5lieA, 0.7172, 3.14, 0.164, 379, 359, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
1593, 4l36B, 0.7165, 3.73, 0.145, 392, 373, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1594, 5li6A, 0.7162, 3.05, 0.160, 377, 357, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
1595, 4rm4A, 0.7160, 3.28, 0.188, 364, 357, THE CRYSTAL STRUCTURE OF THE VERSATILE CYTOCHROME P450 ENZYME CYP109B1 FROM BACILLUS SUBTILIS
1596, 5li6B, 0.7156, 3.02, 0.163, 376, 356, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
1597, 5ysmA, 0.7134, 2.95, 0.140, 364, 350, CRYSTAL STRUCTURE ANALYSIS OF RIF16 
1598, 5kyoF, 0.7130, 3.70, 0.138, 383, 369, CRYSTAL STRUCTURE OF CYP101J2
1599, 5kyoD, 0.7096, 3.69, 0.136, 384, 369, CRYSTAL STRUCTURE OF CYP101J2
1600, 3b4xA, 0.7084, 3.00, 0.170, 367, 348, CRYSTAL STRUCTURE ANALYSIS OF SULFOLOBUS TOKODAII STRAIN7 CYTOCHROM P450
1601, 2uvnB, 0.7084, 3.54, 0.122, 391, 362, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
1602, 2x9pA, 0.7052, 3.71, 0.144, 385, 362, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
1603, 5mnvG, 0.7049, 3.48, 0.162, 380, 359, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1604, 1ue8A, 0.7046, 3.15, 0.172, 367, 349, CRYSTAL STRUCTURE OF THERMOPHILIC CYTOCHROME P450 FROM SULFOLOBUS TOKODAII
1605, 4z5qA, 0.7038, 3.10, 0.151, 363, 350, CRYSTAL STRUCTURE OF THE LNMZ CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.8 A RESOLUTION
1606, 5li7A, 0.7034, 3.18, 0.164, 373, 353, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1607, 1f4tB, 0.7034, 3.28, 0.187, 367, 352, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1608, 5li7B, 0.7026, 3.11, 0.160, 372, 351, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1609, 1io9A, 0.7023, 3.07, 0.193, 366, 348, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1610, 1io7A, 0.7011, 3.09, 0.193, 366, 348, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1611, 1f4tA, 0.7008, 3.40, 0.187, 367, 353, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1612, 1io8A, 0.7006, 3.18, 0.192, 366, 349, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1613, 4wpdA, 0.7003, 3.39, 0.185, 367, 352, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1614, 4wpdB, 0.7002, 3.35, 0.190, 367, 352, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1615, 5xw2A, 0.7000, 3.37, 0.144, 375, 354, CRYSTAL STRUCTURE OF THE HYDROXYLASE HMTN IN C 1 2 1 CRYSTAL FORM 
1616, 4e2pA, 0.6989, 3.47, 0.138, 370, 355, CRYSTAL STRUCTURE OF A POST-TAILORING HYDROXYLASE (HMTN) INVOLVED IN THE HIMASTATIN BIOSYNTHESIS
1617, 4wqjA, 0.6981, 3.18, 0.193, 367, 348, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COLLECTED AT 298K AND COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1618, 4tuvA, 0.6975, 3.19, 0.193, 367, 348, X-RAY CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1619, 4tt5A, 0.6971, 3.20, 0.193, 367, 348, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1620, 1f4uB, 0.6950, 3.37, 0.195, 366, 348, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1621, 1f4uA, 0.6950, 3.37, 0.195, 366, 348, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1622, 4tvfA, 0.6902, 3.00, 0.135, 352, 342, OXYB FROM ACTINOPLANES TEICHOMYCETICUS
1623, 1io7B, 0.6893, 3.08, 0.190, 359, 342, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1624, 1io8B, 0.6887, 3.09, 0.190, 359, 342, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1625, 1io9B, 0.6855, 3.04, 0.192, 354, 338, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1626, 2rfcD, 0.6782, 2.92, 0.156, 338, 334, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1627, 2rfcA, 0.6782, 2.96, 0.162, 338, 334, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1628, 2rfcC, 0.6776, 2.98, 0.156, 338, 334, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1629, 2rfbA, 0.6712, 3.11, 0.157, 338, 332, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1630, 2rfcB, 0.6685, 3.21, 0.153, 338, 333, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1631, 2rfbC, 0.6628, 3.13, 0.161, 333, 329, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1632, 2rfbB, 0.6625, 3.07, 0.159, 335, 328, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1633, 5bv5D, 0.6271, 3.52, 0.183, 327, 317, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1634, 5bv5A, 0.6228, 3.23, 0.186, 315, 311, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1635, 5bv5C, 0.6101, 3.05, 0.200, 311, 300, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1636, 5bv5B, 0.5817, 2.80, 0.197, 288, 284, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1637, 2yjnB, 0.5758, 3.86, 0.119, 337, 302, STRUCTURE OF THE GLYCOSYLTRANSFERASE ERYCIII FROM THE ERYTHROMYCIN BIOSYNTHETIC PATHWAY IN COMPLEX WITH ITS ACTIVATING PARTNER ERYCII
1638, 5mnvI, 0.5533, 3.36, 0.145, 286, 282, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
